JP2020532307A - カンナビノイド産物の生合成のためのE.Coliの代謝工学 - Google Patents
カンナビノイド産物の生合成のためのE.Coliの代謝工学 Download PDFInfo
- Publication number
- JP2020532307A JP2020532307A JP2020513274A JP2020513274A JP2020532307A JP 2020532307 A JP2020532307 A JP 2020532307A JP 2020513274 A JP2020513274 A JP 2020513274A JP 2020513274 A JP2020513274 A JP 2020513274A JP 2020532307 A JP2020532307 A JP 2020532307A
- Authority
- JP
- Japan
- Prior art keywords
- synthase
- host cell
- expression cassette
- nucleic acid
- cannabinoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003557 cannabinoid Substances 0.000 title claims abstract description 177
- 229930003827 cannabinoid Natural products 0.000 title claims abstract description 177
- 241000588724 Escherichia coli Species 0.000 title description 51
- 230000015572 biosynthetic process Effects 0.000 title description 23
- 238000012269 metabolic engineering Methods 0.000 title description 3
- 150000003505 terpenes Chemical class 0.000 claims abstract description 73
- 238000000034 method Methods 0.000 claims abstract description 70
- 239000000203 mixture Substances 0.000 claims abstract description 39
- 230000014509 gene expression Effects 0.000 claims description 242
- 210000004027 cell Anatomy 0.000 claims description 198
- 150000007523 nucleic acids Chemical class 0.000 claims description 129
- 108020004707 nucleic acids Proteins 0.000 claims description 126
- 102000039446 nucleic acids Human genes 0.000 claims description 126
- 108090000623 proteins and genes Proteins 0.000 claims description 109
- 230000037361 pathway Effects 0.000 claims description 105
- 101150022203 ispDF gene Proteins 0.000 claims description 98
- 102000004190 Enzymes Human genes 0.000 claims description 96
- 108090000790 Enzymes Proteins 0.000 claims description 96
- 239000013612 plasmid Substances 0.000 claims description 77
- 230000001588 bifunctional effect Effects 0.000 claims description 62
- 101001015102 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) Dimethylallyltranstransferase Proteins 0.000 claims description 60
- 101000997933 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) (2E,6E)-farnesyl diphosphate synthase Proteins 0.000 claims description 57
- 239000002207 metabolite Substances 0.000 claims description 44
- 101000712615 Cannabis sativa Tetrahydrocannabinolic acid synthase Proteins 0.000 claims description 39
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical compound CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 claims description 32
- 229940002612 prodrug Drugs 0.000 claims description 32
- 239000000651 prodrug Substances 0.000 claims description 32
- 239000002253 acid Substances 0.000 claims description 31
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 27
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims description 27
- 229960004999 lycopene Drugs 0.000 claims description 27
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims description 27
- 235000012661 lycopene Nutrition 0.000 claims description 27
- 239000001751 lycopene Substances 0.000 claims description 27
- 150000003839 salts Chemical class 0.000 claims description 27
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims description 27
- IRMPFYJSHJGOPE-UHFFFAOYSA-N olivetol Chemical compound CCCCCC1=CC(O)=CC(O)=C1 IRMPFYJSHJGOPE-UHFFFAOYSA-N 0.000 claims description 26
- 150000001413 amino acids Chemical class 0.000 claims description 24
- 108010002861 cannabichromenic acid synthase Proteins 0.000 claims description 21
- 230000001939 inductive effect Effects 0.000 claims description 21
- 239000008194 pharmaceutical composition Substances 0.000 claims description 20
- 108010075293 Cannabidiolic acid synthase Proteins 0.000 claims description 19
- 230000001965 increasing effect Effects 0.000 claims description 18
- 101150068863 ispE gene Proteins 0.000 claims description 18
- 230000004907 flux Effects 0.000 claims description 17
- 239000013592 cell lysate Substances 0.000 claims description 14
- 210000003754 fetus Anatomy 0.000 claims description 14
- 108010075483 isoprene synthase Proteins 0.000 claims description 13
- 101100180240 Burkholderia pseudomallei (strain K96243) ispH2 gene Proteins 0.000 claims description 12
- 241000218236 Cannabis Species 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 12
- 101150118992 dxr gene Proteins 0.000 claims description 12
- 101150017044 ispH gene Proteins 0.000 claims description 12
- 108010071062 pinene cyclase I Proteins 0.000 claims description 12
- 101100126492 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) ispG1 gene Proteins 0.000 claims description 11
- 230000013595 glycosylation Effects 0.000 claims description 11
- 101150081094 ispG gene Proteins 0.000 claims description 11
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 10
- 101100268917 Oryctolagus cuniculus ACOX2 gene Proteins 0.000 claims description 10
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 10
- UCONUSSAWGCZMV-UHFFFAOYSA-N Tetrahydro-cannabinol-carbonsaeure Natural products O1C(C)(C)C2CCC(C)=CC2C2=C1C=C(CCCCC)C(C(O)=O)=C2O UCONUSSAWGCZMV-UHFFFAOYSA-N 0.000 claims description 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 10
- 238000006206 glycosylation reaction Methods 0.000 claims description 10
- 238000012217 deletion Methods 0.000 claims description 9
- 230000037430 deletion Effects 0.000 claims description 9
- 238000012258 culturing Methods 0.000 claims description 8
- 101100072830 Campylobacter fetus subsp. fetus (strain 82-40) ispDF gene Proteins 0.000 claims description 7
- 101100072836 Campylobacter jejuni (strain RM1221) ispDF gene Proteins 0.000 claims description 7
- 101100072835 Campylobacter jejuni subsp. jejuni serotype O:23/36 (strain 81-176) ispDF gene Proteins 0.000 claims description 7
- 241000589989 Helicobacter Species 0.000 claims description 7
- 241000590000 Helicobacter acinonychis Species 0.000 claims description 7
- 101100452893 Helicobacter acinonychis (strain Sheeba) ispDF gene Proteins 0.000 claims description 7
- 101100452897 Helicobacter pylori (strain HPAG1) ispDF gene Proteins 0.000 claims description 7
- 101100509104 Helicobacter pylori (strain J99 / ATCC 700824) ispDF gene Proteins 0.000 claims description 7
- 241000589597 Paracoccus denitrificans Species 0.000 claims description 7
- 101100114901 Streptomyces griseus crtI gene Proteins 0.000 claims description 7
- 101100233436 Sulfurimonas denitrificans (strain ATCC 33889 / DSM 1251) ispDF gene Proteins 0.000 claims description 7
- 101100180060 Wolinella succinogenes (strain ATCC 29543 / DSM 1740 / LMG 7466 / NCTC 11488 / FDC 602W) ispDF gene Proteins 0.000 claims description 7
- 101150081158 crtB gene Proteins 0.000 claims description 7
- 101150000046 crtE gene Proteins 0.000 claims description 7
- 239000012453 solvate Substances 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 5
- 101100398785 Streptococcus agalactiae serotype V (strain ATCC BAA-611 / 2603 V/R) ldhD gene Proteins 0.000 claims description 4
- 101100386830 Zymomonas mobilis subsp. mobilis (strain ATCC 31821 / ZM4 / CP4) ddh gene Proteins 0.000 claims description 4
- 101150014383 adhE gene Proteins 0.000 claims description 4
- 210000004748 cultured cell Anatomy 0.000 claims description 4
- 101150026107 ldh1 gene Proteins 0.000 claims description 4
- 101150041530 ldha gene Proteins 0.000 claims description 4
- 101100084110 Bacillus subtilis (strain 168) pps gene Proteins 0.000 claims description 2
- 101150097247 CRT1 gene Proteins 0.000 claims description 2
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 claims description 2
- 101150013950 DLD gene Proteins 0.000 claims description 2
- 101100499356 Dictyostelium discoideum lpd gene Proteins 0.000 claims description 2
- 101100137465 Escherichia coli (strain K12) ppsA gene Proteins 0.000 claims description 2
- 101100508818 Mus musculus Inpp5k gene Proteins 0.000 claims description 2
- 230000002934 lysing effect Effects 0.000 claims description 2
- SEEZIOZEUUMJME-FOWTUZBSSA-N cannabigerolic acid Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-FOWTUZBSSA-N 0.000 claims 2
- SEEZIOZEUUMJME-UHFFFAOYSA-N cannabinerolic acid Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1C(O)=O SEEZIOZEUUMJME-UHFFFAOYSA-N 0.000 claims 2
- HRHJHXJQMNWQTF-UHFFFAOYSA-N cannabichromenic acid Chemical compound O1C(C)(CCC=C(C)C)C=CC2=C1C=C(CCCCC)C(C(O)=O)=C2O HRHJHXJQMNWQTF-UHFFFAOYSA-N 0.000 claims 1
- WVOLTBSCXRRQFR-DLBZAZTESA-M cannabidiolate Chemical compound OC1=C(C([O-])=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-M 0.000 claims 1
- 229940065144 cannabinoids Drugs 0.000 abstract description 54
- 238000010586 diagram Methods 0.000 abstract description 5
- -1 CBCA Natural products 0.000 description 62
- 238000004519 manufacturing process Methods 0.000 description 61
- 150000001875 compounds Chemical class 0.000 description 50
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 description 46
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 description 45
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 description 34
- 239000002609 medium Substances 0.000 description 33
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 29
- 239000000047 product Substances 0.000 description 29
- 102000004169 proteins and genes Human genes 0.000 description 28
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 description 26
- 235000001014 amino acid Nutrition 0.000 description 26
- 229950011318 cannabidiol Drugs 0.000 description 26
- 101100278777 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) dxs1 gene Proteins 0.000 description 24
- 101150056470 dxs gene Proteins 0.000 description 24
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 24
- 239000002243 precursor Substances 0.000 description 24
- 235000018102 proteins Nutrition 0.000 description 24
- 101150018742 ispF gene Proteins 0.000 description 23
- 101100509110 Leifsonia xyli subsp. xyli (strain CTCB07) ispDF gene Proteins 0.000 description 22
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 description 22
- 229930003658 monoterpene Natural products 0.000 description 21
- 230000000699 topical effect Effects 0.000 description 21
- 101100152417 Bacillus spizizenii (strain ATCC 23059 / NRRL B-14472 / W23) tarI gene Proteins 0.000 description 20
- 101150014059 ispD gene Proteins 0.000 description 20
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 18
- 239000002028 Biomass Substances 0.000 description 17
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 description 17
- 238000006243 chemical reaction Methods 0.000 description 17
- 235000002577 monoterpenes Nutrition 0.000 description 17
- 239000000758 substrate Substances 0.000 description 17
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 description 15
- 150000002773 monoterpene derivatives Chemical class 0.000 description 15
- 229910052757 nitrogen Inorganic materials 0.000 description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 14
- 229910019142 PO4 Inorganic materials 0.000 description 14
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 description 14
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 description 14
- 239000000546 pharmaceutical excipient Substances 0.000 description 14
- 230000000694 effects Effects 0.000 description 13
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 12
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 12
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 238000001727 in vivo Methods 0.000 description 12
- 239000010452 phosphate Substances 0.000 description 12
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 238000000855 fermentation Methods 0.000 description 11
- 230000004151 fermentation Effects 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 11
- UAHWPYUMFXYFJY-UHFFFAOYSA-N beta-myrcene Chemical compound CC(C)=CCCC(=C)C=C UAHWPYUMFXYFJY-UHFFFAOYSA-N 0.000 description 10
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 10
- 238000005755 formation reaction Methods 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 9
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 239000013543 active substance Substances 0.000 description 9
- 239000012039 electrophile Substances 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 9
- 125000006239 protecting group Chemical group 0.000 description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 230000004186 co-expression Effects 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000000411 inducer Substances 0.000 description 8
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 7
- 244000025254 Cannabis sativa Species 0.000 description 7
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 7
- 101100286286 Dictyostelium discoideum ipi gene Proteins 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 101150014423 fni gene Proteins 0.000 description 7
- 101150075592 idi gene Proteins 0.000 description 7
- 230000006698 induction Effects 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 229920001184 polypeptide Polymers 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- VWFJDQUYCIWHTN-YFVJMOTDSA-N 2-trans,6-trans-farnesyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-YFVJMOTDSA-N 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 235000008697 Cannabis sativa Nutrition 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 108010006519 Molecular Chaperones Proteins 0.000 description 6
- 229920002675 Polyoxyl Polymers 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 6
- 125000003277 amino group Chemical group 0.000 description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 6
- 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 6
- 125000000524 functional group Chemical group 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 108020004999 messenger RNA Proteins 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 230000010076 replication Effects 0.000 description 6
- NDVASEGYNIMXJL-UHFFFAOYSA-N sabinene Chemical compound C=C1CCC2(C(C)C)C1C2 NDVASEGYNIMXJL-UHFFFAOYSA-N 0.000 description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 125000003396 thiol group Chemical group [H]S* 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 101100397224 Bacillus subtilis (strain 168) isp gene Proteins 0.000 description 5
- 102000009135 CB2 Cannabinoid Receptor Human genes 0.000 description 5
- 108010073376 CB2 Cannabinoid Receptor Proteins 0.000 description 5
- VWFJDQUYCIWHTN-UHFFFAOYSA-N Farnesyl pyrophosphate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-UHFFFAOYSA-N 0.000 description 5
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 5
- 108090000854 Oxidoreductases Proteins 0.000 description 5
- 102000004316 Oxidoreductases Human genes 0.000 description 5
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 5
- 101100052502 Shigella flexneri yciB gene Proteins 0.000 description 5
- 101100061456 Streptomyces griseus crtB gene Proteins 0.000 description 5
- VYBREYKSZAROCT-UHFFFAOYSA-N alpha-myrcene Natural products CC(=C)CCCC(=C)C=C VYBREYKSZAROCT-UHFFFAOYSA-N 0.000 description 5
- 239000005557 antagonist Substances 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 101150011633 crtI gene Proteins 0.000 description 5
- 229960004242 dronabinol Drugs 0.000 description 5
- 239000002621 endocannabinoid Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 101150064873 ispA gene Proteins 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 229940076788 pyruvate Drugs 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 239000002562 thickening agent Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 description 4
- 108030005203 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthases Proteins 0.000 description 4
- SFRQRNJMIIUYDI-RFZPGFLSSA-N 2c-methyl-d-erythritol 2,4-cyclodiphosphate Chemical compound OC[C@@]1(C)O[P@@](O)(=O)O[P@](O)(=O)OC[C@H]1O SFRQRNJMIIUYDI-RFZPGFLSSA-N 0.000 description 4
- HTJXTKBIUVFUAR-XHIBXCGHSA-N 4-CDP-2-C-methyl-D-erythritol 2-phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@](CO)(OP(O)(O)=O)C)O[C@H]1N1C(=O)N=C(N)C=C1 HTJXTKBIUVFUAR-XHIBXCGHSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000018208 Cannabinoid Receptor Human genes 0.000 description 4
- 108050007331 Cannabinoid receptor Proteins 0.000 description 4
- 102100036214 Cannabinoid receptor 2 Human genes 0.000 description 4
- 101710187022 Cannabinoid receptor 2 Proteins 0.000 description 4
- UCONUSSAWGCZMV-HZPDHXFCSA-N Delta(9)-tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 description 4
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 108090000769 Isomerases Proteins 0.000 description 4
- 102000004195 Isomerases Human genes 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 150000001200 N-acyl ethanolamides Chemical class 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 4
- 235000019483 Peanut oil Nutrition 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 239000012190 activator Substances 0.000 description 4
- 125000000266 alpha-aminoacyl group Chemical group 0.000 description 4
- 239000002260 anti-inflammatory agent Substances 0.000 description 4
- 229940121375 antifungal agent Drugs 0.000 description 4
- 239000003429 antifungal agent Substances 0.000 description 4
- 108060000514 aromatic prenyltransferase Proteins 0.000 description 4
- 150000001718 carbodiimides Chemical class 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 239000000969 carrier Substances 0.000 description 4
- 238000006555 catalytic reaction Methods 0.000 description 4
- 238000004132 cross linking Methods 0.000 description 4
- 125000004122 cyclic group Chemical group 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 235000001510 limonene Nutrition 0.000 description 4
- 229940087305 limonene Drugs 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 239000012038 nucleophile Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000002018 overexpression Effects 0.000 description 4
- 239000000312 peanut oil Substances 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- LHLICFIVOBVHOL-UHFFFAOYSA-N 2-(5-methyl-2-prop-1-en-2-ylcyclohex-2-en-1-yl)-5-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC(O)=C(C2CC(C)CC=C2C(C)=C)C(O)=C1 LHLICFIVOBVHOL-UHFFFAOYSA-N 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 3
- 108030004173 4-hydroxy-3-methylbut-2-enyl diphosphate reductases Proteins 0.000 description 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 239000005711 Benzoic acid Substances 0.000 description 3
- VBGLYOIFKLUMQG-UHFFFAOYSA-N Cannabinol Chemical compound C1=C(C)C=C2C3=C(O)C=C(CCCCC)C=C3OC(C)(C)C2=C1 VBGLYOIFKLUMQG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241000186216 Corynebacterium Species 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- 108010006731 Dimethylallyltranstransferase Proteins 0.000 description 3
- 102000005454 Dimethylallyltranstransferase Human genes 0.000 description 3
- 241000588722 Escherichia Species 0.000 description 3
- 108010026318 Geranyltranstransferase Proteins 0.000 description 3
- 108091006905 Human Serum Albumin Proteins 0.000 description 3
- 102000008100 Human Serum Albumin Human genes 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- HGVJFBSSLICXEM-UHFFFAOYSA-N L-2-methyl-erythritol Natural products OCC(O)(C)C(O)CO HGVJFBSSLICXEM-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 241000194036 Lactococcus Species 0.000 description 3
- 239000004472 Lysine Substances 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 244000057717 Streptococcus lactis Species 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 150000001412 amines Chemical class 0.000 description 3
- 239000001099 ammonium carbonate Substances 0.000 description 3
- 235000012501 ammonium carbonate Nutrition 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000012752 auxiliary agent Substances 0.000 description 3
- 229960000686 benzalkonium chloride Drugs 0.000 description 3
- 235000010233 benzoic acid Nutrition 0.000 description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 235000005687 corn oil Nutrition 0.000 description 3
- 239000002285 corn oil Substances 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229960001484 edetic acid Drugs 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000013613 expression plasmid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 229960002714 fluticasone Drugs 0.000 description 3
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 125000005179 haloacetyl group Chemical group 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- 150000002513 isocyanates Chemical class 0.000 description 3
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 150000002924 oxiranes Chemical class 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 229930001119 polyketide Natural products 0.000 description 3
- 150000003881 polyketide derivatives Chemical class 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 230000013823 prenylation Effects 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000000069 prophylactic effect Effects 0.000 description 3
- 230000012846 protein folding Effects 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 229930006696 sabinene Natural products 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 239000008159 sesame oil Substances 0.000 description 3
- 235000011803 sesame oil Nutrition 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 239000003549 soybean oil Substances 0.000 description 3
- 235000012424 soybean oil Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 108010087432 terpene synthase Proteins 0.000 description 3
- 235000007586 terpenes Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 229960004418 trolamine Drugs 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- MDSIZRKJVDMQOQ-GORDUTHDSA-K (2E)-4-hydroxy-3-methylbut-2-enyl diphosphate(3-) Chemical compound OCC(/C)=C/COP([O-])(=O)OP([O-])([O-])=O MDSIZRKJVDMQOQ-GORDUTHDSA-K 0.000 description 2
- HGVJFBSSLICXEM-UHNVWZDZSA-N (2s,3r)-2-methylbutane-1,2,3,4-tetrol Chemical compound OC[C@@](O)(C)[C@H](O)CO HGVJFBSSLICXEM-UHNVWZDZSA-N 0.000 description 2
- MDSIZRKJVDMQOQ-UHFFFAOYSA-N (4-hydroxy-3-methylbut-2-enyl) phosphono hydrogen phosphate Chemical compound OCC(C)=CCOP(O)(=O)OP(O)(O)=O MDSIZRKJVDMQOQ-UHFFFAOYSA-N 0.000 description 2
- IQSYWEWTWDEVNO-ZIAGYGMSSA-N (6ar,10ar)-1-hydroxy-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromene-2-carboxylic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCC)C(C(O)=O)=C1O IQSYWEWTWDEVNO-ZIAGYGMSSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- CZXWOKHVLNYAHI-LSDHHAIUSA-N 2,4-dihydroxy-3-[(1r,6r)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-6-propylbenzoic acid Chemical compound OC1=C(C(O)=O)C(CCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 CZXWOKHVLNYAHI-LSDHHAIUSA-N 0.000 description 2
- WHCIPUBSRQYMLV-UHFFFAOYSA-N 2-(5-methyl-2-prop-1-en-2-ylcyclohex-3-en-1-yl)-5-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC(O)=C(C2CC(C)C=CC2C(C)=C)C(O)=C1 WHCIPUBSRQYMLV-UHFFFAOYSA-N 0.000 description 2
- KLYPAQJXUITNGB-UHFFFAOYSA-N 2-(5-methylidene-2-prop-1-en-2-ylcyclohexyl)-5-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC(O)=C(C2CC(=C)CCC2C(C)=C)C(O)=C1 KLYPAQJXUITNGB-UHFFFAOYSA-N 0.000 description 2
- RCRCTBLIHCHWDZ-UHFFFAOYSA-N 2-Arachidonoyl Glycerol Chemical compound CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC(CO)CO RCRCTBLIHCHWDZ-UHFFFAOYSA-N 0.000 description 2
- SFRQRNJMIIUYDI-UHNVWZDZSA-N 2-C-Methyl-D-erythritol 2,4-cyclodiphosphate Natural products OC[C@]1(C)OP(O)(=O)OP(O)(=O)OC[C@H]1O SFRQRNJMIIUYDI-UHNVWZDZSA-N 0.000 description 2
- ZTGXAWYVTLUPDT-ZWKOTPCHSA-N 2-[(1r,6r)-3-methyl-6-prop-1-en-2-ylcyclohex-3-en-1-yl]-5-pentylbenzene-1,3-diol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-ZWKOTPCHSA-N 0.000 description 2
- AJTVSSFTXWNIRG-UHFFFAOYSA-N 2-[bis(2-hydroxyethyl)amino]ethanesulfonic acid Chemical compound OCC[NH+](CCO)CCS([O-])(=O)=O AJTVSSFTXWNIRG-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 2
- OINNEUNVOZHBOX-QIRCYJPOSA-K 2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-) Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP([O-])(=O)OP([O-])([O-])=O OINNEUNVOZHBOX-QIRCYJPOSA-K 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- DVLFYONBTKHTER-UHFFFAOYSA-N 3-(N-morpholino)propanesulfonic acid Chemical compound OS(=O)(=O)CCCN1CCOCC1 DVLFYONBTKHTER-UHFFFAOYSA-N 0.000 description 2
- INEWUCPYEUEQTN-UHFFFAOYSA-N 3-(cyclohexylamino)-2-hydroxy-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CNC1CCCCC1 INEWUCPYEUEQTN-UHFFFAOYSA-N 0.000 description 2
- FAVCTJGKHFHFHJ-GXDHUFHOSA-N 3-[(2e)-3,7-dimethylocta-2,6-dienyl]-2,4-dihydroxy-6-propylbenzoic acid Chemical compound CCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1C(O)=O FAVCTJGKHFHFHJ-GXDHUFHOSA-N 0.000 description 2
- RZQXOGQSPBYUKH-UHFFFAOYSA-N 3-[[1,3-dihydroxy-2-(hydroxymethyl)propan-2-yl]azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCC(CO)(CO)NCC(O)CS(O)(=O)=O RZQXOGQSPBYUKH-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- YFAUKWZNPVBCFF-XHIBXCGHSA-N 4-CDP-2-C-methyl-D-erythritol Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H](O)[C@@](O)(CO)C)O[C@H]1N1C(=O)N=C(N)C=C1 YFAUKWZNPVBCFF-XHIBXCGHSA-N 0.000 description 2
- CFKMVGJGLGKFKI-UHFFFAOYSA-N 4-chloro-m-cresol Chemical compound CC1=CC(O)=CC=C1Cl CFKMVGJGLGKFKI-UHFFFAOYSA-N 0.000 description 2
- 101710166309 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase Proteins 0.000 description 2
- OIVPAQDCMDYIIL-UHFFFAOYSA-N 5-hydroxy-2-methyl-2-(4-methylpent-3-enyl)-7-propylchromene-6-carboxylic acid Chemical compound O1C(C)(CCC=C(C)C)C=CC2=C1C=C(CCC)C(C(O)=O)=C2O OIVPAQDCMDYIIL-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- ALQFAGFPQCBPED-UHFFFAOYSA-N AM2201 Chemical compound C12=CC=CC=C2N(CCCCCF)C=C1C(=O)C1=CC=CC2=CC=CC=C12 ALQFAGFPQCBPED-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 239000004254 Ammonium phosphate Substances 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 238000009010 Bradford assay Methods 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 102000009132 CB1 Cannabinoid Receptor Human genes 0.000 description 2
- 108010073366 CB1 Cannabinoid Receptor Proteins 0.000 description 2
- CZXWOKHVLNYAHI-UHFFFAOYSA-N CBDVA Natural products OC1=C(C(O)=O)C(CCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 CZXWOKHVLNYAHI-UHFFFAOYSA-N 0.000 description 2
- FAVCTJGKHFHFHJ-UHFFFAOYSA-N CBGVA Natural products CCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1C(O)=O FAVCTJGKHFHFHJ-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000589877 Campylobacter coli Species 0.000 description 2
- 241000589875 Campylobacter jejuni Species 0.000 description 2
- KASVLYINZPAMNS-UHFFFAOYSA-N Cannabigerol monomethylether Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(OC)=C1 KASVLYINZPAMNS-UHFFFAOYSA-N 0.000 description 2
- 102100033868 Cannabinoid receptor 1 Human genes 0.000 description 2
- 101100166240 Cannabis sativa CBDAS gene Proteins 0.000 description 2
- 108050001186 Chaperonin Cpn60 Proteins 0.000 description 2
- 102000052603 Chaperonins Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 102100031515 D-ribitol-5-phosphate cytidylyltransferase Human genes 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 102100035111 Farnesyl pyrophosphate synthase Human genes 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 description 2
- 102000013404 Geranyltranstransferase Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 101000994204 Homo sapiens D-ribitol-5-phosphate cytidylyltransferase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 101710163622 Isoprenyl transferase Proteins 0.000 description 2
- JDNLPKCAXICMBW-UHFFFAOYSA-N JWH 018 Chemical compound C12=CC=CC=C2N(CCCCC)C=C1C(=O)C1=CC=CC2=CC=CC=C12 JDNLPKCAXICMBW-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 102000003820 Lipoxygenases Human genes 0.000 description 2
- 108090000128 Lipoxygenases Proteins 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 102100034068 Monocarboxylate transporter 1 Human genes 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- 108030004881 Myrcene synthases Proteins 0.000 description 2
- DBXNUXBLKRLWFA-UHFFFAOYSA-N N-(2-acetamido)-2-aminoethanesulfonic acid Chemical compound NC(=O)CNCCS(O)(=O)=O DBXNUXBLKRLWFA-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 2
- FOUZISDNESEYLX-UHFFFAOYSA-N N-hydroxyethyl glycine Natural products OCCNCC(O)=O FOUZISDNESEYLX-UHFFFAOYSA-N 0.000 description 2
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 229920002685 Polyoxyl 35CastorOil Polymers 0.000 description 2
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 108020005091 Replication Origin Proteins 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- IQSYWEWTWDEVNO-UHFFFAOYSA-N THCVA Natural products O1C(C)(C)C2CCC(C)=CC2C2=C1C=C(CCC)C(C(O)=O)=C2O IQSYWEWTWDEVNO-UHFFFAOYSA-N 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XMWHRVNVKDKBRG-CRCLSJGQSA-N [(2s,3r)-2,3,4-trihydroxy-3-methylbutyl] dihydrogen phosphate Chemical compound OC[C@](O)(C)[C@@H](O)COP(O)(O)=O XMWHRVNVKDKBRG-CRCLSJGQSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 239000002535 acidifier Substances 0.000 description 2
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- 230000003113 alkalizing effect Effects 0.000 description 2
- 150000001345 alkine derivatives Chemical group 0.000 description 2
- 125000005206 alkoxycarbonyloxymethyl group Chemical group 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 2
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 2
- 235000019289 ammonium phosphates Nutrition 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 150000001502 aryl halides Chemical class 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 2
- 229960001950 benzethonium chloride Drugs 0.000 description 2
- 150000001558 benzoic acid derivatives Chemical class 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000004067 bulking agent Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229960003453 cannabinol Drugs 0.000 description 2
- 235000013877 carbamide Nutrition 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 2
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- NFCRBQADEGXVDL-UHFFFAOYSA-M cetylpyridinium chloride monohydrate Chemical compound O.[Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NFCRBQADEGXVDL-UHFFFAOYSA-M 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000008139 complexing agent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 2
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 229940043237 diethanolamine Drugs 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 2
- 235000011180 diphosphates Nutrition 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 150000004141 diterpene derivatives Chemical class 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N dodecane Chemical compound CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- 238000009510 drug design Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- 125000003147 glycosyl group Chemical group 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 108010064894 hydroperoxide lyase Proteins 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 150000002540 isothiocyanates Chemical class 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- LSTDYDRCKUBPDI-UHFFFAOYSA-N palmityl acetate Chemical compound CCCCCCCCCCCCCCCCOC(C)=O LSTDYDRCKUBPDI-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229940124531 pharmaceutical excipient Drugs 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 229940099429 polyoxyl 40 stearate Drugs 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229960003975 potassium Drugs 0.000 description 2
- 235000011118 potassium hydroxide Nutrition 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 229940095064 tartrate Drugs 0.000 description 2
- 229940116411 terpineol Drugs 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- NDVASEGYNIMXJL-NXEZZACHSA-N (+)-sabinene Natural products C=C1CC[C@@]2(C(C)C)[C@@H]1C2 NDVASEGYNIMXJL-NXEZZACHSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- RVCNKTPCHZNAAO-UZDKSQMHSA-N (1R,2R,3R)-prephytoene diphosphate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\[C@@H]1[C@@H](COP(O)(=O)OP(O)(O)=O)[C@]1(C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C RVCNKTPCHZNAAO-UZDKSQMHSA-N 0.000 description 1
- 101710165761 (2E,6E)-farnesyl diphosphate synthase Proteins 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- MEJYDZQQVZJMPP-ULAWRXDQSA-N (3s,3ar,6r,6ar)-3,6-dimethoxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan Chemical compound CO[C@H]1CO[C@@H]2[C@H](OC)CO[C@@H]21 MEJYDZQQVZJMPP-ULAWRXDQSA-N 0.000 description 1
- ZROLHBHDLIHEMS-HUUCEWRRSA-N (6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCC)=CC(O)=C3[C@@H]21 ZROLHBHDLIHEMS-HUUCEWRRSA-N 0.000 description 1
- AOYYFUGUUIRBML-IAGOWNOFSA-N (6ar,10ar)-6,6-dimethyl-9-methylidene-3-pentyl-7,8,10,10a-tetrahydro-6ah-benzo[c]chromen-1-ol Chemical compound C1C(=C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 AOYYFUGUUIRBML-IAGOWNOFSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 1
- 125000005862 (C1-C6)alkanoyl group Chemical group 0.000 description 1
- 125000005859 (C1-C6)alkanoyloxymethyl group Chemical group 0.000 description 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 description 1
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- JCIIKRHCWVHVFF-UHFFFAOYSA-N 1,2,4-thiadiazol-5-amine;hydrochloride Chemical compound Cl.NC1=NC=NS1 JCIIKRHCWVHVFF-UHFFFAOYSA-N 0.000 description 1
- 125000005851 1-(N-(alkoxycarbonyl)amino)ethyl group Chemical group 0.000 description 1
- 125000005848 1-(alkoxycarbonyloxy)ethyl group Chemical group 0.000 description 1
- VCHHHSMPMLNVGS-UHFFFAOYSA-N 1-Butyl-3-(1-naphthoyl)indole Chemical compound C12=CC=CC=C2N(CCCC)C=C1C(=O)C1=CC=CC2=CC=CC=C12 VCHHHSMPMLNVGS-UHFFFAOYSA-N 0.000 description 1
- AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 1
- RRQYJINTUHWNHW-UHFFFAOYSA-N 1-ethoxy-2-(2-ethoxyethoxy)ethane Chemical compound CCOCCOCCOCC RRQYJINTUHWNHW-UHFFFAOYSA-N 0.000 description 1
- KXKOBIRSQLNUPS-UHFFFAOYSA-N 1-hydroxy-6,6,9-trimethyl-3-pentylbenzo[c]chromene-2-carboxylic acid Chemical compound O1C(C)(C)C2=CC=C(C)C=C2C2=C1C=C(CCCCC)C(C(O)=O)=C2O KXKOBIRSQLNUPS-UHFFFAOYSA-N 0.000 description 1
- SDTORDSXCYSNTD-UHFFFAOYSA-N 1-methoxy-4-[(4-methoxyphenyl)methoxymethyl]benzene Chemical compound C1=CC(OC)=CC=C1COCC1=CC=C(OC)C=C1 SDTORDSXCYSNTD-UHFFFAOYSA-N 0.000 description 1
- 125000005847 1-methyl-1-(alkanoyloxy)-ethyl group Chemical group 0.000 description 1
- 125000005849 1-methyl-1-(alkoxycarbonyloxy)ethyl group Chemical group 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- JLGKQTAYUIMGRK-UHFFFAOYSA-N 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound ClC1=CC(Cl)=CC=C1C(OCC=1C2=CC=CC(Cl)=C2SC=1)CN1C=NC=C1 JLGKQTAYUIMGRK-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical class CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- VFYPGSAVZLVUEQ-UHFFFAOYSA-N 1h-isochromen-1-ol Chemical compound C1=CC=C2C(O)OC=CC2=C1 VFYPGSAVZLVUEQ-UHFFFAOYSA-N 0.000 description 1
- IHPYMWDTONKSCO-UHFFFAOYSA-N 2,2'-piperazine-1,4-diylbisethanesulfonic acid Chemical compound OS(=O)(=O)CCN1CCN(CCS(O)(=O)=O)CC1 IHPYMWDTONKSCO-UHFFFAOYSA-N 0.000 description 1
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- HCSBTDBGTNZOAB-UHFFFAOYSA-N 2,3-dinitrobenzoic acid Chemical class OC(=O)C1=CC=CC([N+]([O-])=O)=C1[N+]([O-])=O HCSBTDBGTNZOAB-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- XCVYBASXVCEZLB-UHFFFAOYSA-N 2-(3-methyl-6-prop-1-en-2-ylcyclohexen-1-yl)-5-pentylbenzene-1,3-diol Chemical compound CCCCCC1=CC(O)=C(C(O)=C1)C1=CC(C)CCC1C(C)=C XCVYBASXVCEZLB-UHFFFAOYSA-N 0.000 description 1
- KUXGUCNZFCVULO-UHFFFAOYSA-N 2-(4-nonylphenoxy)ethanol Chemical compound CCCCCCCCCC1=CC=C(OCCO)C=C1 KUXGUCNZFCVULO-UHFFFAOYSA-N 0.000 description 1
- YFWFRYYNEQXILR-UHFFFAOYSA-N 2-(5-methyl-2-prop-1-en-2-ylcyclohexen-1-yl)-5-pentylbenzene-1,3-diol Chemical compound CCCCCc1cc(O)c(C2=C(CCC(C)C2)C(C)=C)c(O)c1 YFWFRYYNEQXILR-UHFFFAOYSA-N 0.000 description 1
- XMWHRVNVKDKBRG-UHNVWZDZSA-N 2-C-methyl-D-erythritol 4-(dihydrogen phosphate) Chemical compound OC[C@@](O)(C)[C@H](O)COP(O)(O)=O XMWHRVNVKDKBRG-UHNVWZDZSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- YNZFFALZMRAPHQ-SYYKKAFVSA-N 2-[(1r,2r,5r)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol Chemical compound OC1=CC(C(C)(C)CCCCCC)=CC=C1[C@H]1[C@H](CCCO)CC[C@@H](O)C1 YNZFFALZMRAPHQ-SYYKKAFVSA-N 0.000 description 1
- OIALAIQRYISUEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]e Polymers CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO OIALAIQRYISUEV-UHFFFAOYSA-N 0.000 description 1
- HNLXNOZHXNSSPN-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCOCCOCCOCCO)C=C1 HNLXNOZHXNSSPN-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- CUJUUWXZAQHCNC-DOFZRALJSA-N 2-arachidonyl glyceryl ether Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCCOC(CO)CO CUJUUWXZAQHCNC-DOFZRALJSA-N 0.000 description 1
- IKCLCGXPQILATA-UHFFFAOYSA-N 2-chlorobenzoic acid Chemical class OC(=O)C1=CC=CC=C1Cl IKCLCGXPQILATA-UHFFFAOYSA-N 0.000 description 1
- 125000001731 2-cyanoethyl group Chemical group [H]C([H])(*)C([H])([H])C#N 0.000 description 1
- AVGLYNCSDWUUMH-UHFFFAOYSA-N 2-hydroxy-2-methyloctadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(C)(O)C(O)=O AVGLYNCSDWUUMH-UHFFFAOYSA-N 0.000 description 1
- ACERFIHBIWMFOR-UHFFFAOYSA-N 2-hydroxy-3-[(1-hydroxy-2-methylpropan-2-yl)azaniumyl]propane-1-sulfonate Chemical compound OCC(C)(C)NCC(O)CS(O)(=O)=O ACERFIHBIWMFOR-UHFFFAOYSA-N 0.000 description 1
- LVQFQZZGTZFUNF-UHFFFAOYSA-N 2-hydroxy-3-[4-(2-hydroxy-3-sulfonatopropyl)piperazine-1,4-diium-1-yl]propane-1-sulfonate Chemical compound OS(=O)(=O)CC(O)CN1CCN(CC(O)CS(O)(=O)=O)CC1 LVQFQZZGTZFUNF-UHFFFAOYSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- HSXUNHYXJWDLDK-UHFFFAOYSA-N 2-hydroxypropane-1-sulfonic acid Chemical compound CC(O)CS(O)(=O)=O HSXUNHYXJWDLDK-UHFFFAOYSA-N 0.000 description 1
- MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
- HGVJFBSSLICXEM-CRCLSJGQSA-N 2-methylerythritol Chemical compound OC[C@](O)(C)[C@@H](O)CO HGVJFBSSLICXEM-CRCLSJGQSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- WFCSWCVEJLETKA-UHFFFAOYSA-N 2-piperazin-1-ylethanol Chemical compound OCCN1CCNCC1 WFCSWCVEJLETKA-UHFFFAOYSA-N 0.000 description 1
- YEYKMVJDLWJFOA-UHFFFAOYSA-N 2-propoxyethanol Chemical compound CCCOCCO YEYKMVJDLWJFOA-UHFFFAOYSA-N 0.000 description 1
- HRGUSFBJBOKSML-UHFFFAOYSA-N 3',5'-di-O-methyltricetin Chemical compound COC1=C(O)C(OC)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 HRGUSFBJBOKSML-UHFFFAOYSA-N 0.000 description 1
- 125000002774 3,4-dimethoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- NUFBIAUZAMHTSP-UHFFFAOYSA-N 3-(n-morpholino)-2-hydroxypropanesulfonic acid Chemical compound OS(=O)(=O)CC(O)CN1CCOCC1 NUFBIAUZAMHTSP-UHFFFAOYSA-N 0.000 description 1
- XCBLFURAFHFFJF-UHFFFAOYSA-N 3-[bis(2-hydroxyethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound OCCN(CCO)CC(O)CS(O)(=O)=O XCBLFURAFHFFJF-UHFFFAOYSA-N 0.000 description 1
- WDXXEUARVHTWQF-ZYMOGRSISA-N 3-hydroxy-2-[(1r)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C(CCCCC)=CC(=O)C([C@H]2C(CCC(C)=C2)C(C)=C)=C1O WDXXEUARVHTWQF-ZYMOGRSISA-N 0.000 description 1
- WDXXEUARVHTWQF-DLBZAZTESA-N 3-hydroxy-2-[(1r,6r)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C(CCCCC)=CC(=O)C([C@H]2[C@@H](CCC(C)=C2)C(C)=C)=C1O WDXXEUARVHTWQF-DLBZAZTESA-N 0.000 description 1
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 1
- XMGKYXFDYYTZFD-UHFFFAOYSA-N 4-amino-1-hydroxy-2-methylbutane-2-sulfonic acid Chemical compound OCC(C)(S(O)(=O)=O)CCN XMGKYXFDYYTZFD-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- OBKXEAXTFZPCHS-UHFFFAOYSA-N 4-phenylbutyric acid Chemical compound OC(=O)CCCC1=CC=CC=C1 OBKXEAXTFZPCHS-UHFFFAOYSA-N 0.000 description 1
- LUMNWCHHXDUKFI-UHFFFAOYSA-N 5-bicyclo[2.2.1]hept-2-enylmethanol Chemical compound C1C2C(CO)CC1C=C2 LUMNWCHHXDUKFI-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- XZOYHFBNQHPJRQ-UHFFFAOYSA-N 7-methyloctanoic acid Chemical compound CC(C)CCCCCC(O)=O XZOYHFBNQHPJRQ-UHFFFAOYSA-N 0.000 description 1
- 239000007991 ACES buffer Substances 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 101710194331 Acetyl-coenzyme A synthetase 1 Proteins 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101100161363 Arabidopsis thaliana AAE1 gene Proteins 0.000 description 1
- 101100000149 Arabidopsis thaliana AAE3 gene Proteins 0.000 description 1
- MVVPIAAVGAWJNQ-DOFZRALJSA-N Arachidonoyl dopamine Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCC1=CC=C(O)C(O)=C1 MVVPIAAVGAWJNQ-DOFZRALJSA-N 0.000 description 1
- 108700016232 Arg(2)-Sar(4)- dermorphin (1-4) Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 101100010589 Bacillus anthracis dxr1 gene Proteins 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical group C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 1
- 101100453077 Botryococcus braunii HDR gene Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- MYPAEIGHLDOPLZ-RGMNGODLSA-N CC(CO)O.NCCCC[C@@H](CO)N Chemical compound CC(CO)O.NCCCC[C@@H](CO)N MYPAEIGHLDOPLZ-RGMNGODLSA-N 0.000 description 1
- 239000008000 CHES buffer Substances 0.000 description 1
- HPQKNJHVWUWAOR-BYYUCUBISA-N C[C@H](CC[C@@H]1C(=C)CC[C@H]2[C@@]1(C)CCC[C@@]2(C)C(O)=O)CC(O)=O Chemical compound C[C@H](CC[C@@H]1C(=C)CC[C@H]2[C@@]1(C)CCC[C@@]2(C)C(O)=O)CC(O)=O HPQKNJHVWUWAOR-BYYUCUBISA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 235000005273 Canna coccinea Nutrition 0.000 description 1
- 240000008555 Canna flaccida Species 0.000 description 1
- 101000910925 Cannabis sativa Cannabidiolic acid synthase Proteins 0.000 description 1
- 101100242103 Cannabis sativa OLS gene Proteins 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 101710118490 Copalyl diphosphate synthase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101710095468 Cyclase Proteins 0.000 description 1
- PJWWRFATQTVXHA-UHFFFAOYSA-N Cyclohexylaminopropanesulfonic acid Chemical compound OS(=O)(=O)CCCNC1CCCCC1 PJWWRFATQTVXHA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- UCONUSSAWGCZMV-HZPDHXFCSA-M Delta(9)-tetrahydrocannabinolate Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C([O-])=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-M 0.000 description 1
- ZROLHBHDLIHEMS-UHFFFAOYSA-N Delta9 tetrahydrocannabivarin Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCC)=CC(O)=C3C21 ZROLHBHDLIHEMS-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 241000457135 Escherichia coli B354 Species 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- VWFJDQUYCIWHTN-FBXUGWQNSA-N Farnesyl diphosphate Natural products CC(C)=CCC\C(C)=C/CC\C(C)=C/COP(O)(=O)OP(O)(O)=O VWFJDQUYCIWHTN-FBXUGWQNSA-N 0.000 description 1
- 101710156207 Farnesyl diphosphate synthase Proteins 0.000 description 1
- 101710125754 Farnesyl pyrophosphate synthase Proteins 0.000 description 1
- 101710089428 Farnesyl pyrophosphate synthase erg20 Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- OWXMKDGYPWMGEB-UHFFFAOYSA-N HEPPS Chemical compound OCCN1CCN(CCCS(O)(=O)=O)CC1 OWXMKDGYPWMGEB-UHFFFAOYSA-N 0.000 description 1
- 239000007996 HEPPS buffer Substances 0.000 description 1
- GIZQLVPDAOBAFN-UHFFFAOYSA-N HEPPSO Chemical compound OCCN1CCN(CC(O)CS(O)(=O)=O)CC1 GIZQLVPDAOBAFN-UHFFFAOYSA-N 0.000 description 1
- MUQNGPZZQDCDFT-JNQJZLCISA-N Halcinonide Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CCl)[C@@]1(C)C[C@@H]2O MUQNGPZZQDCDFT-JNQJZLCISA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- YSBFLLZNALVODA-RBUKOAKNSA-N JWH-133 Chemical compound C1C(C)=CC[C@H]2C(C)(C)OC3=CC(C(C)(C)CCC)=CC=C3[C@@H]21 YSBFLLZNALVODA-RBUKOAKNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 102000005431 Molecular Chaperones Human genes 0.000 description 1
- 108700038057 Monocarboxylate transporter 1 Proteins 0.000 description 1
- 101000997616 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) 4-hydroxy-3-methylbut-2-enyl diphosphate reductase 1 Proteins 0.000 description 1
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 1
- 125000005855 N,N-di(C1-C2)alkylcarbamoyl-(C1-C2)alkyl group Chemical group 0.000 description 1
- 125000005850 N-(alkoxycarbonyl)aminomethyl group Chemical group 0.000 description 1
- OTGQIQQTPXJQRG-UHFFFAOYSA-N N-(octadecanoyl)ethanolamine Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCCO OTGQIQQTPXJQRG-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical class ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 230000004988 N-glycosylation Effects 0.000 description 1
- SEQKRHFRPICQDD-UHFFFAOYSA-N N-tris(hydroxymethyl)methylglycine Chemical compound OCC(CO)(CO)[NH2+]CC([O-])=O SEQKRHFRPICQDD-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- DLHLOYYQQGSXCC-DOFZRALJSA-N O-Arachidonoyl ethanolamine Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OCCN DLHLOYYQQGSXCC-DOFZRALJSA-N 0.000 description 1
- ILUJQPXNXACGAN-UHFFFAOYSA-N O-methylsalicylic acid Chemical class COC1=CC=CC=C1C(O)=O ILUJQPXNXACGAN-UHFFFAOYSA-N 0.000 description 1
- HPQKNJHVWUWAOR-UHFFFAOYSA-N Oliveric acid Natural products C1CCC(C(O)=O)(C)C2C1(C)C(CCC(C)CC(O)=O)C(=C)CC2 HPQKNJHVWUWAOR-UHFFFAOYSA-N 0.000 description 1
- VZPLPGICHZXOCQ-UHFFFAOYSA-N Olivetoric acid Chemical compound CCCCCC(=O)CC1=CC(O)=CC(O)=C1C(=O)OC1=CC(O)=C(C(O)=O)C(CCCCC)=C1 VZPLPGICHZXOCQ-UHFFFAOYSA-N 0.000 description 1
- BAZIREYQKLPBSI-UHFFFAOYSA-N Olivetoric acid Natural products CCCCCCC(=O)c1cc(O)cc(O)c1C(=O)Oc2cc(O)c(C(=O)O)c(CCCCC)c2 BAZIREYQKLPBSI-UHFFFAOYSA-N 0.000 description 1
- 101710199606 Oxalate-CoA ligase Proteins 0.000 description 1
- YYVFXSYQSOZCOQ-UHFFFAOYSA-N Oxyquinoline sulfate Chemical compound [O-]S([O-])(=O)=O.C1=C[NH+]=C2C(O)=CC=CC2=C1.C1=C[NH+]=C2C(O)=CC=CC2=C1 YYVFXSYQSOZCOQ-UHFFFAOYSA-N 0.000 description 1
- 239000007990 PIPES buffer Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241000520272 Pantoea Species 0.000 description 1
- 101710093888 Pentalenene synthase Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101710173432 Phytoene synthase Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- 101001135788 Pinus taeda (+)-alpha-pinene synthase, chloroplastic Proteins 0.000 description 1
- IDDMFNIRSJVBHE-UHFFFAOYSA-N Piscigenin Natural products COC1=C(O)C(OC)=CC(C=2C(C3=C(O)C=C(O)C=C3OC=2)=O)=C1 IDDMFNIRSJVBHE-UHFFFAOYSA-N 0.000 description 1
- 101100397457 Plasmodium falciparum (isolate 3D7) LytB gene Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- 229920002669 Polyoxyl 20 Cetostearyl Ether Polymers 0.000 description 1
- 229920001219 Polysorbate 40 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 101001078108 Populus alba Isoprene synthase, chloroplastic Proteins 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 101710150389 Probable farnesyl diphosphate synthase Proteins 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- SUGVYNSRNKFXQM-XRHWURSXSA-N SR 144528 Chemical compound C1=CC(C)=CC=C1CN1C(C=2C=C(C)C(Cl)=CC=2)=CC(C(=O)N[C@@H]2C([C@@H]3CC[C@@]2(C)C3)(C)C)=N1 SUGVYNSRNKFXQM-XRHWURSXSA-N 0.000 description 1
- 101100012578 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) PCS60 gene Proteins 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- RJFAYQIBOAGBLC-BYPYZUCNSA-N Selenium-L-methionine Chemical compound C[Se]CC[C@H](N)C(O)=O RJFAYQIBOAGBLC-BYPYZUCNSA-N 0.000 description 1
- 101710115850 Sesquiterpene synthase Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 101710174833 Tuberculosinyl adenosine transferase Proteins 0.000 description 1
- 208000034953 Twin anemia-polycythemia sequence Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HQVHOQAKMCMIIM-HXUWFJFHSA-N WIN 55212-2 Chemical compound C([C@@H]1COC=2C=CC=C3C(C(=O)C=4C5=CC=CC=C5C=CC=4)=C(N1C3=2)C)N1CCOCC1 HQVHOQAKMCMIIM-HXUWFJFHSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- AAQLWZRNSJGQGC-UHFFFAOYSA-N acetamide;formic acid Chemical compound OC=O.CC(N)=O AAQLWZRNSJGQGC-UHFFFAOYSA-N 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 150000008063 acylals Chemical class 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 101150063416 add gene Proteins 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 229920013820 alkyl cellulose Polymers 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000005303 alkyl halide derivatives Chemical class 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- HGLAYHSJJRYIBI-UHFFFAOYSA-N allyl diphosphate Chemical compound OP(O)(=O)OP(O)(=O)OCC=C HGLAYHSJJRYIBI-UHFFFAOYSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 description 1
- 229940070312 arachidyl propionate Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 125000005251 aryl acyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-L aspartate group Chemical class N[C@@H](CC(=O)[O-])C(=O)[O-] CKLJMWTZIZZHCS-REOHCLBHSA-L 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 150000001541 aziridines Chemical class 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Chemical class 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 150000003936 benzamides Chemical class 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000010338 boric acid Nutrition 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000005854 carbamoyl-(C1-C2)alkyl group Chemical group 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 150000007942 carboxylates Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 229940084030 carboxymethylcellulose calcium Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229940049297 cetyl acetate Drugs 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical class OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 229960002242 chlorocresol Drugs 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical compound C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229960002842 clobetasol Drugs 0.000 description 1
- FCSHDIVRCWTZOX-DVTGEIKXSA-N clobetasol Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O FCSHDIVRCWTZOX-DVTGEIKXSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 101150017073 cmk1 gene Proteins 0.000 description 1
- 230000008045 co-localization Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- 229940013361 cresol Drugs 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- HCAWPGARWVBULJ-IAGOWNOFSA-N delta8-THC Chemical compound C1C(C)=CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 HCAWPGARWVBULJ-IAGOWNOFSA-N 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- WBGKWQHBNHJJPZ-LECWWXJVSA-N desonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O WBGKWQHBNHJJPZ-LECWWXJVSA-N 0.000 description 1
- 229960003662 desonide Drugs 0.000 description 1
- 229960002593 desoximetasone Drugs 0.000 description 1
- VWVSBHGCDBMOOT-IIEHVVJPSA-N desoximetasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@H](C(=O)CO)[C@@]1(C)C[C@@H]2O VWVSBHGCDBMOOT-IIEHVVJPSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 125000005852 di-N,N—(C1-C2)alkylamino(C2-C3)alkyl group Chemical group 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- WXURHACBFYSXBI-XHIJKXOTSA-N diflorasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H](C)[C@@](C(=O)CO)(O)[C@@]2(C)C[C@@H]1O WXURHACBFYSXBI-XHIJKXOTSA-N 0.000 description 1
- 229960004154 diflorasone Drugs 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- KCFYHBSOLOXZIF-UHFFFAOYSA-N dihydrochrysin Natural products COC1=C(O)C(OC)=CC(C2OC3=CC(O)=CC(O)=C3C(=O)C2)=C1 KCFYHBSOLOXZIF-UHFFFAOYSA-N 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- FSBVERYRVPGNGG-UHFFFAOYSA-N dimagnesium dioxido-bis[[oxido(oxo)silyl]oxy]silane hydrate Chemical compound O.[Mg+2].[Mg+2].[O-][Si](=O)O[Si]([O-])([O-])O[Si]([O-])=O FSBVERYRVPGNGG-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- QBEFIFWEOSUTKV-UHFFFAOYSA-N dimethylheptylpyran Chemical compound CC1(C)OC2=CC(C(C)C(C)CCCCC)=CC(O)=C2C2=C1CCC(C)C2 QBEFIFWEOSUTKV-UHFFFAOYSA-N 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical compound [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 125000000567 diterpene group Chemical group 0.000 description 1
- 150000004887 dithianes Chemical class 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 238000011143 downstream manufacturing Methods 0.000 description 1
- 230000007783 downstream signaling Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 229960003937 efinaconazole Drugs 0.000 description 1
- NFEZZTICAUWDHU-RDTXWAMCSA-N efinaconazole Chemical compound N1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)CCC(=C)CC1 NFEZZTICAUWDHU-RDTXWAMCSA-N 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000008387 emulsifying waxe Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical compound CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 150000003948 formamides Chemical class 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229940083124 ganglion-blocking antiadrenergic secondary and tertiary amines Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 125000002686 geranylgeranyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 102000035122 glycosylated proteins Human genes 0.000 description 1
- 108091005608 glycosylated proteins Proteins 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 229960002383 halcinonide Drugs 0.000 description 1
- 229940115747 halobetasol Drugs 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- 150000002373 hemiacetals Chemical group 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 1
- 150000004687 hexahydrates Chemical class 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- GYTMUNSNMBRSEW-UHFFFAOYSA-N hydrogen carbonate;1h-imidazol-1-ium Chemical class OC(O)=O.C1=CNC=N1 GYTMUNSNMBRSEW-UHFFFAOYSA-N 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- OPEHDFRKFVXKNP-UHFFFAOYSA-N icosyl propanoate Chemical compound CCCCCCCCCCCCCCCCCCCCOC(=O)CC OPEHDFRKFVXKNP-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940001447 lactate Drugs 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 229940040452 linolenate Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000019792 magnesium silicate Nutrition 0.000 description 1
- 229910052919 magnesium silicate Inorganic materials 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- NSPJNIDYTSSIIY-UHFFFAOYSA-N methoxy(methoxymethoxy)methane Chemical compound COCOCOC NSPJNIDYTSSIIY-UHFFFAOYSA-N 0.000 description 1
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical class COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 229940043265 methyl isobutyl ketone Drugs 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960003476 methylparaben sodium Drugs 0.000 description 1
- CPZBTYRIGVOOMI-UHFFFAOYSA-N methylsulfanyl(methylsulfanylmethoxy)methane Chemical compound CSCOCSC CPZBTYRIGVOOMI-UHFFFAOYSA-N 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 239000013081 microcrystal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229960001664 mometasone Drugs 0.000 description 1
- QLIIKPVHVRXHRI-CXSFZGCWSA-N mometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CCl)(O)[C@@]1(C)C[C@@H]2O QLIIKPVHVRXHRI-CXSFZGCWSA-N 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
- 125000005858 morpholino(C2-C3)alkyl group Chemical group 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229960003128 mupirocin Drugs 0.000 description 1
- 229930187697 mupirocin Natural products 0.000 description 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229950003169 nonoxinol Drugs 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 150000007823 ocimene derivatives Chemical class 0.000 description 1
- OIPZNTLJVJGRCI-UHFFFAOYSA-M octadecanoyloxyaluminum;dihydrate Chemical compound O.O.CCCCCCCCCCCCCCCCCC(=O)O[Al] OIPZNTLJVJGRCI-UHFFFAOYSA-M 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- FATBGEAMYMYZAF-UHFFFAOYSA-N oleicacidamide-heptaglycolether Natural products CCCCCCCCC=CCCCCCCCC(N)=O FATBGEAMYMYZAF-UHFFFAOYSA-N 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000000424 optical density measurement Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 150000002905 orthoesters Chemical class 0.000 description 1
- 229940116315 oxalic acid Drugs 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 150000002918 oxazolines Chemical class 0.000 description 1
- 229960003483 oxiconazole Drugs 0.000 description 1
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 description 1
- 229960001257 oxyquinoline sulfate Drugs 0.000 description 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000003961 penetration enhancing agent Substances 0.000 description 1
- 229940086560 pentaerythrityl tetrastearate Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical class OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 101150104606 pgl gene Proteins 0.000 description 1
- 229960003742 phenol Drugs 0.000 description 1
- DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical class CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical class OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- 229950009215 phenylbutanoic acid Drugs 0.000 description 1
- 229940067107 phenylethyl alcohol Drugs 0.000 description 1
- 229940096826 phenylmercuric acetate Drugs 0.000 description 1
- PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 1
- NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 125000001095 phosphatidyl group Chemical group 0.000 description 1
- ACVYVLVWPXVTIT-UHFFFAOYSA-N phosphinic acid Chemical compound O[PH2]=O ACVYVLVWPXVTIT-UHFFFAOYSA-N 0.000 description 1
- 229960004838 phosphoric acid Drugs 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 108010001545 phytoene dehydrogenase Proteins 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920001522 polyglycol ester Polymers 0.000 description 1
- 229920002704 polyhistidine Polymers 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 229940101027 polysorbate 40 Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- OQZCJRJRGMMSGK-UHFFFAOYSA-M potassium metaphosphate Chemical compound [K+].[O-]P(=O)=O OQZCJRJRGMMSGK-UHFFFAOYSA-M 0.000 description 1
- 229940099402 potassium metaphosphate Drugs 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960001896 pramocaine Drugs 0.000 description 1
- DQKXQSGTHWVTAD-UHFFFAOYSA-N pramocaine Chemical compound C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 DQKXQSGTHWVTAD-UHFFFAOYSA-N 0.000 description 1
- 229960002794 prednicarbate Drugs 0.000 description 1
- FNPXMHRZILFCKX-KAJVQRHHSA-N prednicarbate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)CC)(OC(=O)OCC)[C@@]1(C)C[C@@H]2O FNPXMHRZILFCKX-KAJVQRHHSA-N 0.000 description 1
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- BFZNCPXNOGIELB-UHFFFAOYSA-N propan-2-yl 10-[5,6-dihexyl-2-(8-oxo-8-propan-2-yloxyoctyl)cyclohex-3-en-1-yl]dec-9-enoate Chemical compound CCCCCCC1C=CC(CCCCCCCC(=O)OC(C)C)C(C=CCCCCCCCC(=O)OC(C)C)C1CCCCCC BFZNCPXNOGIELB-UHFFFAOYSA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000001273 protein sequence alignment Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000009790 rate-determining step (RDS) Methods 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- STZYTFJPGGDRJD-NHUWBDDWSA-N retapamulin Chemical compound C([C@H]([C@@]1(C)[C@@H](C[C@@](C)(C=C)[C@@H](O)[C@@H]2C)OC(=O)CS[C@@H]3C[C@H]4CC[C@H](N4C)C3)C)C[C@]32[C@H]1C(=O)CC3 STZYTFJPGGDRJD-NHUWBDDWSA-N 0.000 description 1
- 229960002771 retapamulin Drugs 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229960005429 sertaconazole Drugs 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 230000007727 signaling mechanism Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229960003600 silver sulfadiazine Drugs 0.000 description 1
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical compound [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 229910000342 sodium bisulfate Inorganic materials 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 description 1
- 229940001584 sodium metabisulfite Drugs 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 229940080350 sodium stearate Drugs 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 229940001474 sodium thiosulfate Drugs 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- PESXGULMKCKJCC-UHFFFAOYSA-M sodium;4-methoxycarbonylphenolate Chemical compound [Na+].COC(=O)C1=CC=C([O-])C=C1 PESXGULMKCKJCC-UHFFFAOYSA-M 0.000 description 1
- IXMINYBUNCWGER-UHFFFAOYSA-M sodium;4-propoxycarbonylphenolate Chemical compound [Na+].CCCOC(=O)C1=CC=C([O-])C=C1 IXMINYBUNCWGER-UHFFFAOYSA-M 0.000 description 1
- 244000000000 soil microbiome Species 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960002607 sulconazole Drugs 0.000 description 1
- 229960000551 sulfacetamide sodium Drugs 0.000 description 1
- IHCDKJZZFOUARO-UHFFFAOYSA-M sulfacetamide sodium Chemical compound O.[Na+].CC(=O)[N-]S(=O)(=O)C1=CC=C(N)C=C1 IHCDKJZZFOUARO-UHFFFAOYSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 229940044609 sulfur dioxide Drugs 0.000 description 1
- 235000010269 sulphur dioxide Nutrition 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 1
- 229960002722 terbinafine Drugs 0.000 description 1
- FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- BORJONZPSTVSFP-UHFFFAOYSA-N tetradecyl 2-hydroxypropanoate Chemical compound CCCCCCCCCCCCCCOC(=O)C(C)O BORJONZPSTVSFP-UHFFFAOYSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- ZUHZGEOKBKGPSW-UHFFFAOYSA-N tetraglyme Chemical compound COCCOCCOCCOCCOC ZUHZGEOKBKGPSW-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 125000000101 thioether group Chemical group 0.000 description 1
- 150000007873 thujene derivatives Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- XJPBRODHZKDRCB-UHFFFAOYSA-N trans-alpha-ocimene Natural products CC(=C)CCC=C(C)C=C XJPBRODHZKDRCB-UHFFFAOYSA-N 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 229960005294 triamcinolone Drugs 0.000 description 1
- GFNANZIMVAIWHM-OBYCQNJPSA-N triamcinolone Chemical compound O=C1C=C[C@]2(C)[C@@]3(F)[C@@H](O)C[C@](C)([C@@]([C@H](O)C4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 GFNANZIMVAIWHM-OBYCQNJPSA-N 0.000 description 1
- BMCJATLPEJCACU-UHFFFAOYSA-N tricin Natural products COc1cc(OC)c(O)c(c1)C2=CC(=O)c3c(O)cc(O)cc3O2 BMCJATLPEJCACU-UHFFFAOYSA-N 0.000 description 1
- RRBYUSWBLVXTQN-VZCHMASFSA-N tricyclene Natural products C([C@@H]12)C3C[C@H]1C2(C)C3(C)C RRBYUSWBLVXTQN-VZCHMASFSA-N 0.000 description 1
- RRBYUSWBLVXTQN-UHFFFAOYSA-N tricyclene Chemical compound C12CC3CC2C1(C)C3(C)C RRBYUSWBLVXTQN-UHFFFAOYSA-N 0.000 description 1
- 150000004684 trihydrates Chemical class 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- LEHFPXVYPMWYQD-XHIJKXOTSA-N ulobetasol Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H](C)[C@@](C(=O)CCl)(O)[C@@]2(C)C[C@@H]1O LEHFPXVYPMWYQD-XHIJKXOTSA-N 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GDJZZWYLFXAGFH-UHFFFAOYSA-M xylenesulfonate group Chemical group C1(C(C=CC=C1)C)(C)S(=O)(=O)[O-] GDJZZWYLFXAGFH-UHFFFAOYSA-M 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 125000005863 α-amino(C1-C4)alkanoyl group Chemical group 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P5/00—Preparation of hydrocarbons or halogenated hydrocarbons
- C12P5/007—Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y121/00—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21)
- C12Y121/03—Oxidoreductases acting on X-H and Y-H to form an X-Y bond (1.21) with oxygen as acceptor (1.21.3)
- C12Y121/03007—Tetrahydrocannabinolic acid synthase (1.21.3.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y201/00—Transferases transferring one-carbon groups (2.1)
- C12Y201/01—Methyltransferases (2.1.1)
- C12Y201/01255—Geranyl diphosphate 2-C-methyltransferase (2.1.1.255)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/0706—2-C-Methyl-D-erythritol 4-phosphate cytidylyltransferase (2.7.7.60)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y402/00—Carbon-oxygen lyases (4.2)
- C12Y402/03—Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
- C12Y402/03027—Isoprene synthase (4.2.3.27)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本出願は、米国仮特許出願第62/554,494号の優先権を主張しており、その全内容を、本明細書の一部を構成するものとして、また、あらゆる目的のために援用する。
本出願は、ASCII形式で電子的に提出した配列表を含んでおり、そして、その全内容を、本明細書の一部を構成するものとして援用する。当該ASCIIコピーは、2018年10月17日に作成したものであり、NMD−003_PCT_SL.txtの名称を付けており、そして、サイズは、109,691バイトである。
本明細書で言及したすべての刊行物、特許、及び、特許出願を、個々の刊行物、特許、及び、特許出願の内容を援用することを個別かつ具体的に明示しているのと同然のものとして、本明細書の一部を構成するものとして援用する。
本明細書では、以下の略語を使用する:「G3P」は、グリセルアルデヒド 3−リン酸を意味する;「DOXP」は、1−デオキシ−D−キシルロース 5−リン酸を意味する;「MEP」は、2−C−メチルエリトリトール 4−リン酸を意味する;「CDP−ME」は、4−ジホスホシチジル−2−C−メチルエリトリトールを意味する;「CDP−MEP」は、4−ジホスホシチジル−2−C−メチル−D−エリトリトール 2−リン酸を意味する;「MECPP」は、2−C−メチル−D−エリトリトール 2,4−シクロ二リン酸を意味する;「HMBPP」は、(E)−4−ヒドロキシ−3−メチル−ブト−2−エニルピロリン酸を意味する;「IPP」は、イソペンテニル二リン酸を意味する;「DMAPP」は、ジメチルアリル二リン酸を意味する;「GPP」は、ゲラニルピロリン酸を意味する。
カンナビノイド類は、皮膚など、人体全体の細胞のカンナビノイド受容体を活性化することが知られている化学物質のグループである。フィトカンナビノイド類は、大麻植物に由来するカンナビノイド類である。それらは、植物から単離するか、あるいは、合成的に生産することができる。内因性カンナビノイド類は、人体に認められる内因性のカンナビノイド類である。標準的なフィトカンナビノイド類は、ベンゾピラン部分を担持しているABC三環式テルペノイド化合物である。
本明細書では、宿主細胞において、1つ以上の標的遺伝子を発現するのに適した発現カセットを記載している。本明細書に記載した発現カセットは、プラスミドの成分とすることができ、または、宿主細胞ゲノムに組み込むことができる。単一のプラスミドは、本明細書に記載した1つ以上の発現カセットを含むことができる。本明細書での使用では、2つ以上の発現カセットを記載しており、代替的に、2つ以上の発現カセットの少なくとも2つを組み合わせて、発現カセットの数を減らすことができる、と理解する。同様に、複数の標的遺伝子を、単一のプロモーターに機能的に連結していると記載しており、したがって、単一の発現カセットの成分として記載してあると、当該単一の発現カセットが、説明をした単一の発現カセットの重複または非重複のサブセットを含む2つ以上の発現カセットに細分できる、と理解する。
MIALQRSLSMHVTAIIAAAGEGRRLGAPLPKQLLDIGGRSILERSVMAFARHERIDDVIVVLPPAL
AAAPPDWIAASGRVPAVHVVSGGERRQDSVANAFDRVPAQSDVVLVHDAARPFVTAELISRAI
DGAMQHGAAIVAVPVRDTVKRVDPDGEHPVITGTIPRDTIYLAQTPQAFRRDVLGAAVALGRSG
VSATDEAMLAEQAGHRVHVVEGDPANVKITTSADLDQARQRLRSAVAARIGTGYDLHRLIEGR
PLIIGGVAVPCDKGALGHSDADVACHAVIDALLGAAGAGNVGQHYPDTDPRWKGASSIGLLRD
ALRLVQERGFTVENVDVCVVLERPKIAPFIPEIRARIAGALGIDPERVSVKGKTNEGVDAVGRGE
AIAAHAVALLSES.
上記した発現カセットのいずれか、及び、それらの組み合わせを、適切な宿主細胞に導入し、そして、標的テルペノイド、または、カンナビノイドの生産のために使用することができる。適切な宿主細胞として、Escherichia, Panteoa, Corynebacterium, Bacillus,または、Lactococcus属の原核生物などがあるが、これらの原核生物に限定されない。好ましい原核生物宿主細胞として、Escherichia coli(E. coli), Panteoa citrea, C. glutamicum, Bacillus subtilis,及び、Lactococcus lactisがあるが、これらに限定されない。一部の実施形態では、本明細書に記載した発現カセットは、1つ以上の標的遺伝子(例えば、MEP経路遺伝子、カンナビノイドシンターゼ遺伝子、ispA、ispS、ispDF、または、GPPシンターゼ)をコードする核酸に機能的に連結したプロモーター(例えば、異種プロモーター)を含み、1つ以上の標的遺伝子をコードする当該核酸が、発現カセットを含む宿主細胞に最適化したコドンである。
本発明は、誘導条件下、適切な培地で本発明の宿主細胞を培養して、標的代謝産物を生産するプロセスをさらに提供する。当該標的代謝産物を、カンナビノイド、テルペノイド、または、それらの前駆体とすることができる。この方法は、使用済培地、及び/または、当該宿主細胞において、当該代謝産物を濃縮することを含むことができる。
当該標的代謝産物を、医薬組成物に製剤することができる。一部の事例では、使用済培地、または、濃縮使用済培地、または、当該使用済培地に由来する一部または全体を精製した標的代謝産物、または、本明細書に記載の培養方法で得たバイオマスを、医薬組成物に製剤する。
以下の刊行物を、本明細書の一部を構成するものとして援用する。本明細書では、これらの刊行物を以下の番号で示す。この刊行物のリストに、あらゆる刊行物を含めることは、本明細書に記載したあらゆる刊行物が、先行技術であることを承認するものではない。
・JAMA. 2006;295(7): 761−775
・Comput Struct Biotechnol J, 2012, 3, 1−11
・Biotechnol.Bioeng.2004 88, 909−915.
・Science 2002, 298 (5599), 1790−3.
E.coliでのMEP経路の遺伝子操作
当該MEP経路は、その熱力学的な都合の良さと、適切な細菌宿主システムの利用可能性に関して選択した。当該MEP経路は、宿主E.coliに固有である。この実験では、E.coli BL21(DE3)を発現宿主として選択した。当該MEP経路の律速酵素をコードする遺伝子を、カンナビノイド前駆体の生産を最大化するために過剰発現した。
E.coliでの下流経路カンナビノイドシンターゼ遺伝子のクローニング及び発現
序論:
カンナビゲロール酸(CBGA)は、その他のカンナビノイド類の合成のための親化合物である。CBGAは、CBGAシンターゼ(芳香族プレニルトランスフェラーゼファミリーの酵素)が触媒した、オリベトール酸(OA)とゲラニルピロリン酸塩(GPP)との酵素反応で生産される。このプレニル化産物(CBGA)を環化すると、3つの異なるオキシドシクラーゼが触媒して、3つの異なるカンナビノイド生産物がさらに得られる。Δ9−テトラヒドロカンナビノール酸(THCA)シンターゼ、カンナビジオール(CBDA)シンターゼ、及び、カンナビクロム酸(CBCA)シンターゼは、Δ9−テトラヒドロカンナビノール酸(THCA)、カンナビジオール酸(CBDA)、及び、カンナビクロム酸(CBCA)のそれぞれの形成を触媒する。微生物宿主(E.coli)でのこれらのカンナビノイド産物の生合成には、THCAシンターゼ、CBGAシンターゼ、CBCAシンターゼ、CBDAシンターゼ、及び、これらの組み合わせのクローニング、発現、及び、活性決定が関与する。一般的に、カンナビノイド産物は、少なくともCBGAシンターゼを発現する微生物宿主で、任意に、THCAシンターゼ、CBCAシンターゼ、及びCBDAシンターゼの1つ以上と組み合わせて生産する。
E.coliに対してコドン最適化したCannabis sativa由来のCBGAシンターゼ遺伝子を、強力なIPTG誘導性T5プロモーターに機能的に連結したプラスミドベクターに首尾良くクローニングした。このプラスミドは、高コピーのpUC複製起点を含んでおり、かつ、カナマイシン耐性である。CBGAシンターゼのためのプラスミド構築物を、図5に示す。E.coliでの当該CBGAシンターゼの発現を、SDS PAGE分析で確認した(図6)。CBGASの発現を確認した後に、酵素溶液に対して、当該基質(OA及びGPP)を外部から加えて酵素の活性を決定し、そして、自社開発のHPLC法を使用して産物プロファイリングを行った。清澄化した細胞溶解物を、37℃で、OAとGPPとの混合物に対して加えて当該プレニル化反応を行い、そして、当該反応混合物を、酢酸エチルで抽出し、そして、HPLCを実行して当該産物の形成を測定した(図7)。これらの結果は、CBGASが、E.coliで発現することができ、かつ、基質OA及びGPPからCBGAへのプレニル化反応を触媒できることを示した。
当該THCAシンターゼ遺伝子は、強力なIPTG誘導性T5プロモーターの制御下で、高コピーのカナマイシン耐性プラスミドにもクローニングした。この遺伝子挿入は、PCR、及び、遺伝子配列決定で確認した。得られたTHCAシンターゼ遺伝子の発現カセットの概略図を、図9に示す。THCAシンターゼの発現を、IPTG誘導によって行い、そして、細胞溶解物を、SDS PAGEで分析して、発現を確認した。しかしながら、当該THCAシンターゼは、E.coliでは首尾良く発現しなかった。
THCASを、コードしたN末端(当該遺伝子配列の5’末端から84bp)から28個のアミノ酸を除去して切断する。
THCAシンターゼ遺伝子を、pTRCプロモーターの制御下で、アンピシリン耐性、pBR322複製起点を有するプラスミドにクローニングして、シャペロニンシステムと、グリコシルシステムとを有するプラスミドで同時発現するために、異なる複製起点と、適合する複製起点とを有することを確認した(図11)。THCASは、シグナルペプチドの有無に関係なく、E.coliでのタンパク質の折り畳みにおいて、別個ではあるが、協同的に役割を果たす、E.coliの2つの主要なシャペロン経路成分であるDnaK−DnaJ−GrpE、及び、GroEl−GroESと共発現する。E.coliは、そのネイティブなシャペロンシステムを持ち合わせているが、組換えタンパク質の高レベルの生産は、内因性シャペロニンシステムを飽和させ、そして、非生産的な凝集を引き起こすことができる。これらの条件下で、折り畳みを制限している分子シャペロンの細胞内濃度を増加させると、封入体の形成を抑制することができる。日本のTakahashi Yuraのグループは、異なるプロモーター下で、2つのシャペロン経路を持ちあわせたpACYC184をベースとしたプラスミドを構築した。このプラスミド(pG−KJE8)、または、その誘導体は、宿主細胞における活性THCAシンターゼの生産条件を同定するために使用する。
E.coliでのTHCAシンターゼの発現、折り畳み、プロセッシング、溶解度、及び/または、活性の増加には、グリコシル化が必要となり得る。残念ながら、E.coliには、ネイティブなタンパク質グリコシル化システムが無い。Campylobacter jejuni由来のNグリコシル化システム、別名、pglシステムは、E.coliでは首尾良く発現している。C.jejuni pgl系遺伝子を含むプラスミドを提供する。このプラスミド、または、その誘導体は、宿主細胞における活性THCAシンターゼの生産条件を同定するために使用する(図11)。
カンナビノイド経路遺伝子の発現の最適化
E.coliでのCBGAの内因性生産を最適化するために、CBGAシンターゼを、MEP経路、GPPシンターゼ、及び/または、ポリケチド経路成分と同時発現して、CBGAの生産に必要な、基質GPP及びOAを提供する。
・IPP及びDMAPPを生産するMEP経路との共発現
・IPP及びDMAPPからGPPを内因的に供給するGPPシンターゼとの共発現
・オリベトール酸(OA)を内因的に供給するポリケチド経路との共発現、がある。
MEP経路での二官能性ispDF遺伝子のメタゲノムスクリーニング及びクローニング
土壌細菌の環境メタゲノムをスクリーニングして、代替MEP経路遺伝子を特定した。対応するE.coliオルソログよりも活性が非常に大きい非メバロン酸塩経路における新規の二官能性酵素を同定した。その新規の二官能性酵素は、IspD及びIspFの活性部位を、単一のポリペプチド足場に共局在させた。二官能性遺伝子の活性は、カンナビノイド合成を代理して、リコピン生産について評価した。この遺伝子は、ispDFと称されており、そして、同じ強力なRBSを使用して、ispD、及び、ispFを、ispDFで置き換えるpTrc−RDEオペロンでクローニングした。この遺伝子操作したプラスミドを、pTrc−RDE*と命名し、そして、E.coli(DE3)で形質転換した。ispD、及び、ispFの活性部位を共存させる2つのさらなるメタゲノム二官能性酵素を、それぞれを、ispDF2及びispDF3と称した。
プラスミドpTrc−RDE、及び、pTrc−RDE*を含む株を、IPTGを用いた誘導によるタンパク質発現について試験した。細胞を、37℃で、LBブロスにて、ΟD600が0.6に達するまで増殖させ、当該培養培地にIPTGを加えて誘導し、次いで、当該培養物を、30℃で、一晩インキュベートした。培養物から回収した細胞を溶解し、そして、総タンパク質を抽出した。総タンパク質の濃度を、Bradford法で推定し、そして、SDS−PAGEゲルで分析した。これらのゲルを、クーマシーブリリアントブルーG−250色素で染色して、視覚化した。発現時のpTrc−RDE、及び、pTrc−RDE*プラスミドの両方は、SDS−PAGEでの経路酵素に対応するバンドを示した。ispDF発現を、誘導した細胞溶解物のSDS−PAGE分析で示した(図18)。
Campylobacter jejuni由来の二官能性ispDFは、CJ−ispDFとして報告されている。我々の研究で報告したIspDF(ispDFl)を、スイスモデルを使用して、CJ−ispDFでモデル化した。約31%の配列類似性がある。CJ−ispDFと、ネイティブispD及びispFとのアラインメントは、異なるアミノ酸を示す(図19)。このことは、ispDFが、新規であり、また、未だに報告されていないことを示唆している。活性部位の共局在に関するさらなる分析を行っている。
遺伝子操作したE.coli株を、C5イソプレノイド前駆体からリコピンへの変換のための下流遺伝子を含むプラスミドで形質転換した。リコピン生合成遺伝子を、構成的プロモーターの制御下でクローニングした。リコピン発現プラスミドは、低コピーであり、そして、共発現のための複製起点と互換可能であった。
MEP経路の1つ以上の成分の異種発現を介したテルペノイド生合成の増加
テルペノイド生合成の増加を支持する能力について、様々な構築物を試験した(図21)。
E.coliの以下の株を用意した:親のコントロール株(BL21);アラビノースプロモーターに機能的に連結したイソプレンシンターゼ(ispS)をコードする発現カセットを含むコントロール株SA01;SA01での発現カセットと、Trcプロモーターに機能的に結合したdxs、ispD、ispF、及び、idiをコードするRDE発現カセットとを含む株SA02;及び、SA01での発現カセットと、Trcプロモーターに機能的に結合したdxs、ispDF1、及び、idiをコードするRDE*発現カセットとを含むSA03株(図22左)。SA03では、ispDFl−の名称は、ispDF1をコードする核酸が、異種宿主細胞での発現増加のためにコドン最適化がされておらず、一方で、ispDF+(図22に示さず)は、当該酵素をコードする核酸がコドン最適化されている、ことを示す。培養物を、230rpm、30℃で、密閉ガラス培養管内で増殖させた。OD600が0.6に達した後に、培養物を誘導し、そして、さらに20時間インキュベートした。誘導物質として、0.05mM IPTG、及び、10mMアラビノースを使用した。培養物のヘッドスペースを、GC−MSで分析した。試料を注入する前に、70℃にまで加熱した。検量線を使用して、イソプレンを定量した。本明細書に記載した株によるイソプレン生産を、図22の右に示した。
プラスミドpAC−LYC(Addgeneプラスミド#53270)を得た。このプラスミドは、リコピン合成遺伝子crtE、crtI、及び、crtBに機能的に連結した構成的プロモーターを有する発現カセットを含む。Cunningham FX Jr, et al., Plant Cell. 1994 Aug;6(8):1107−21を参照されたい。E.coliの以下の株を用意した:親コントロール株(BL21(DE3));プラスミドpAC−LYCと、上記したRDE発現カセットを含むプラスミドと、を含む株RDE;プラスミドpAC−LYCと、上記したRDE*発現カセットを含むプラスミドと、を含む株RDE*(DF1−);プラスミドpAC−LYCと、コドン最適化したispDF1をコードする核酸を有するRDE*発現カセットを含むプラスミドとを含む株RDE*(DF1+);プラスミドpAC−LYCと、コドン最適化したispDF2をコードする核酸を有するRDE*発現カセットを含むプラスミドと、を含む株RDE*(DF2+);及び、プラスミドpAC−LYCと、コドン最適化したispDF3をコードする核酸を有するRDE*発現カセットを含むプラスミドと、を含む株RDE*(DF3+)。生産したさらなる株として、pAC−LYCを含むSA01;pAC−LYC、及び、pTrc−RDEを含むSA02;pAC−LYC、及び、pTrc−RDEEを含むSA03;pAC−LYC、及び、pTrc−RDE*を含むSA04;及び、pAC−LYC、及び、pTrc−RDE*Eを含むSA05がある。ispDF1、ispDF2、及び、ispDF3の配列を、図26に示す。
図25の上部は、宿主細胞にてモノテルペンを生産するための構築物を示している。当該構築物は、T7プロモーターに機能的に連結した、dxs、コドン最適化したispDF1(DF1+)、及び、idiをコードするMEP経路プラットフォームオペロン、及び、Trcプロモーターに機能的に連結した、GPPシンターゼ、及び、モノテルペンシンターゼをコードするモノテルペンオペロンを含む。この実験では、当該モノテルペンシンターゼは、カレンシンターゼであった。
本出願で言及した例示的な配列として、以下の表に記載したものがあるが、これらに限定されない:
>AB057805.1| テトラヒドロカンナビノール酸シンターゼ(THCAS)、完全cdsについてのCannabis sativa mRNA
ATGAATTGCTCAGCATTTTCCTTTTGGTTTGTTTGCAAAATAAT
ATTTTTCTTTCTCTCATTCCATATCCAAATTTCAATAGCTAATCCTCGAGAAAACTTCCTTAAATGCTTC
TCAAAACATATTCCCAACAATGTAGCAAATCCAAAACTCGTATACACTCAACACGACCAATTGTATATGT
CTATCCTGAATTCGACAATACAAAATCTTAGATTCATCTCTGATACAACCCCAAAACCACTCGTTATTGT
CACTCCTTCAAATAACTCCCATATCCAAGCAACTATTTTATGCTCTAAGAAAGTTGGCTTGCAGATTCGA
ACTCGAAGCGGTGGCCATGATGCTGAGGGTATGTCCTACATATCTCAAGTCCCATTTGTTGTAGTAGACT
TGAGAAACATGCATTCGATCAAAATAGATGTTCATAGCCAAACTGCGTGGGTTGAAGCCGGAGCTACCCT
TGGAGAAGTTTATTATTGGATCAATGAGAAGAATGAGAATCTTAGTTTTCCTGGTGGGTATTGCCCTACT
GTTGGCGTAGGTGGACACTTTAGTGGAGGAGGCTATGGAGCATTGATGCGAAATTATGGCCTTGCGGCTG
ATAATATTATTGATGCACACTTAGTCAATGTTGATGGAAAAGTTCTAGATCGAAAATCCATGGGAGAAGA
TCTGTTTTGGGCTATACGTGGTGGTGGAGGAGAAAACTTTGGAATCATTGCAGCATGGAAAATCAAACTG
GTTGCTGTCCCATCAAAGTCTACTATATTCAGTGTTAAAAAGAACATGGAGATACATGGGCTTGTCAAGT
TATTTAACAAATGGCAAAATATTGCTTACAAGTATGACAAAGATTTAGTACTCATGACTCACTTCATAAC
AAAGAATATTACAGATAATCATGGGAAGAATAAGACTACAGTACATGGTTACTTCTCTTCAATTTTTCAT
GGTGGAGTGGATAGTCTAGTCGACTTGATGAACAAGAGCTTTCCTGAGTTGGGTATTAAAAAAACTGATT
GCAAAGAATTTAGCTGGATTGATACAACCATCTTCTACAGTGGTGTTGTAAATTTTAACACTGCTAATTT
TAAAAAGGAAATTTTGCTTGATAGATCAGCTGGGAAGAAGACGGCTTTCTCAATTAAGTTAGACTATGTT
AAGAAACCAATTCCAGAAACTGCAATGGTCAAAATTTTGGAAAAATTATATGAAGAAGATGTAGGAGCTG
GGATGTATGTGTTGTACCCTTACGGTGGTATAATGGAGGAGATTTCAGAATCAGCAATTCCATTCCCTCA
TCGAGCTGGAATAATGTATGAACTTTGGTACACTGCTTCCTGGGAGAAGCAAGAAGATAATGAAAAGCAT
ATAAACTGGGTTCGAAGTGTTTATAATTTTACGACTCCTTATGTGTCCCAAAATCCAAGATTGGCGTATC
TCAATTATAGGGACCTTGATTTAGGAAAAACTAATCATGCGAGTCCTAATAATTACACACAAGCACGTAT
TTGGGGTGAAAAGTATTTTGGTAAAAATTTTAACAGGTTAGTTAAGGTGAAAACTAAAGTTGATCCCAAT
AATTTTTTTAGAAACGAACAAAGTATCCCACCTCTTCCACCGCATCATCATTAA(配列番号4)
ATGAAGTGCTCAACATTCTCCTTTTGGTTTGTTTGCAAGATAATATTTTTCTTTTTCTCATTCAATATCC
AAACTTCCATTGCTAATCCTCGAGAAAACTTCCTTAAATGCTTCTCGCAATATATTCCCAATAATGCAAC
AAATCTAAAACTCGTATACACTCAAAACAACCCATTGTATATGTCTGTCCTAAATTCGACAATACACAAT
CTTAGATTCACCTCTGACACAACCCCAAAACCACTTGTTATCGTCACTCCTTCACATGTCTCTCATATCC
AAGGCACTATTCTATGCTCCAAGAAAGTTGGCTTGCAGATTCGAACTCGAAGTGGTGGTCATGATTCTGA
GGGCATGTCCTACATATCTCAAGTCCCATTTGTTATAGTAGACTTGAGAAACATGCGTTCAATCAAAATA
GATGTTCATAGCCAAACTGCATGGGTTGAAGCCGGAGCTACCCTTGGAGAAGTTTATTATTGGGTTAATG
AGAAAAATGAGAATCTTAGTTTGGCGGCTGGGTATTGCCCTACTGTTTGCGCAGGTGGACACTTTGGTGG
AGGAGGCTATGGACCATTGATGAGAAACTATGGCCTCGCGGCTGATAATATCATTGATGCACACTTAGTC
AACGTTCATGGAAAAGTGCTAGATCGAAAATCTATGGGGGAAGATCTCTTTTGGGCTTTACGTGGTGGTG
GAGCAGAAAGCTTCGGAATCATTGTAGCATGGAAAATTAGACTGGTTGCTGTCCCAAAGTCTACTATGTT
TAGTGTTAAAAAGATCATGGAGATACATGAGCTTGTCAAGTTAGTTAACAAATGGCAAAATATTGCTTAC
AAGTATGACAAAGATTTATTACTCATGACTCACTTCATAACTAGGAACATTACAGATAATCAAGGGAAGA
ATAAGACAGCAATACACACTTACTTCTCTTCAGTTTTCCTTGGTGGAGTGGATAGTCTAGTCGACTTGAT
GAACAAGAGTTTTCCTGAGTTGGGTATTAAAAAAACGGATTGCAGACAATTGAGCTGGATTGATACTATC
ATCTTCTATAGTGGTGTTGTAAATTACGACACTGATAATTTTAACAAGGAAATTTTGCTTGATAGATCCG
CTGGGCAGAACGGTGCTTTCAAGATTAAGTTAGACTACGTTAAGAAACCAATTCCAGAATCTGTATTTGT
CCAAATTTTGGAAAAATTATATGAAGAAGATATAGGAGCTGGGATGTATGCGTTGTACCCTTACGGTGGT
ATAATGGATGAGATTTCAGAATCAGCAATTCCATTCCCTCATCGAGCTGGAATCTTGTATGAGTTATGGT
ACATATGTAGTTGGGAGAAGCAAGAAGATAACGAAAAGCATCTAAACTGGATTAGAAATATTTATAACTT
CATGACTCCTTATGTGTCCAAAAATCCAAGATTGGCATATCTCAATTATAGAGACCTTGATATAGGAATA
AATGATCCCAAGAATCCAAATAATTACACACAAGCACGTATTTGGGGTGAGAAGTATTTTGGTAAAAATT
TTGACAGGCTAGTAAAAGTGAAAACCCTGGTTGATCCCAATAACTTTTTTAGAAACGAACAAAGCATCCC
ACCTCTTCCACGGCATCGTCATTAA(配列番号5)
ATGAATCCTCGAGAAAACTTCCTTAAATGCTTCTCGCAATATATTCCCAATAATGCAACAAATCTAAAAC
TCGTATACACTCAAAACAACCCATTGTATATGTCTGTCCTAAATTCGACAATACACAATCTTAGATTCAC
CTCTGACACAACCCCAAAACCACTTGTTATCGTCACTCCTTCACATGTCTCTCATATCCAAGGCACTATT
CTATGCTCCAAGAAAGTTGGCTTGCAGATTCGAACTCGAAGTGGTGGTCATGATTCTGAGGGCATGTCCT
ACATATCTCAAGTCCCATTTGTTATAGTAGACTTGAGAAACATGCGTTCAATCAAAATAGATGTTCATAG
CCAAACTGCATGGGTTGAAGCCGGAGCTACCCTTGGAGAAGTTTATTATTGGGTTAATGAGAAAAATGAG
AATCTTAGTTTGGCGGCTGGGTATTGCCCTACTGTTTGCGCAGGTGGACACTTTGGTGGAGGAGGCTATG
GACCATTGATGAGAAACTATGGCCTCGCGGCTGATAATATCATTGATGCACACTTAGTCAACGTTCATGG
AAAAGTGCTAGATCGAAAATCTATGGGGGAAGATCTCTTTTGGGCTTTACGTGGTGGTGGAGCAGAAAGC
TTCGGAATCATTGTAGCATGGAAAATTAGACTGGTTGCTGTCCCAAAGTCTACTATGTTTAGTGTTAAAA
AGATCATGGAGATACATGAGCTTGTCAAGTTAGTTAACAAATGGCAAAATATTGCTTACAAGTATGACAA
AGATTTATTACTCATGACTCACTTCATAACTAGGAACATTACAGATAATCAAGGGAAGAATAAGACAGCA
ATACACACTTACTTCTCTTCAGTTTTCCTTGGTGGAGTGGATAGTCTAGTCGACTTGATGAACAAGAGTT
TTCCTGAGTTGGGTATTAAAAAAACGGATTGCAGACAATTGAGCTGGATTGATACTATCATCTTCTATAG
TGGTGTTGTAAATTACGACACTGATAATTTTAACAAGGAAATTTTGCTTGATAGATCCGCTGGGCAGAAC
GGTGCTTTCAAGATTAAGTTAGACTACGTTAAGAAACCAATTCCAGAATCTGTATTTGTCCAAATTTTGG
AAAAATTATATGAAGAAGATATAGGAGCTGGGATGTATGCGTTGTACCCTTACGGTGGTATAATGGATGA
GATTTCAGAATCAGCAATTCCATTCCCTCATCGAGCTGGAATCTTGTATGAGTTATGGTACATATGTAGT
TGGGAGAAGCAAGAAGATAACGAAAAGCATCTAAACTGGATTAGAAATATTTATAACTTCATGACTCCTT
ATGTGTCCAAAAATCCAAGATTGGCATATCTCAATTATAGAGACCTTGATATAGGAATAAATGATCCCAA
GAATCCAAATAATTACACACAAGCACGTATTTGGGGTGAGAAGTATTTTGGTAAAAATTTTGACAGGCTA
GTAAAAGTGAAAACCCTGGTTGATCCCAATAACTTTTTTAGAAACGAACAAAGCATCCCACCTCTTCCAC
GGCATCGTCATTAA(配列番号6)
ATGGGACTCTCATCAGTTTGTACCTTTTCATTTCAAACTAATTACCATACTTTATTAAATCCTCACAATA
ATAATCCCAAAACCTCATTATTATGTTATCGACACCCCAAAACACCAATTAAATACTCTTACAATAATTT
TCCCTCTAAACATTGCTCCACCAAGAGTTTTCATCTACAAAACAAATGCTCAGAATCATTATCAATCGCA
AAAAATTCCATTAGGGCAGCTACTACAAATCAAACTGAGCCTCCAGAATCTGATAATCATTCAGTAGCAA
CTAAAATTTTAAACTTTGGGAAGGCATGTTGGAAACTTCAAAGACCATATACAATCATAGCATTTACTTC
ATGCGCTTGTGGATTGTTTGGGAAAGAGTTGTTGCATAACACAAATTTAATAAGTTGGTCTCTGATGTTC
AAGGCATTCTTTTTTTTGGTGGCTATATTATGCATTGCTTCTTTTACAACTACCATCAATCAGATTTACG
ATCTTCACATTGACAGAATAAACAAGCCTGATCTACCACTAGCTTCAGGGGAAATATCAGTAAACACAGC
TTGGATTATGAGCATAATTGTGGCACTGTTTGGATTGATAATAACTATAAAAATGAAGGGTGGACCACTC
TATATATTTGGCTACTGTTTTGGTATTTTTGGTGGGATTGTCTATTCTGTTCCACCATTTAGATGGAAGC
AAAATCCTTCCACTGCATTTCTTCTCAATTTCCTGGCCCATATTATTACAAATTTCACATTTTATTATGC
CAGCAGAGCAGCTCTTGGCCTACCATTTGAGTTGAGGCCTTCTTTTACTTTCCTGCTAGCATTTATGAAA
TCAATGGGTTCAGCTTTGGCTTTAATCAAAGATGCTTCAGACGTTGAAGGCGACACTAAATTTGGCATAT
CAACCTTGGCAAGTAAATATGGTTCCAGAAACTTGACATTATTTTGTTCTGGAATTGTTCTCCTATCCTA
TGTGGCTGCTATACTTGCTGGGATTATCTGGCCCCAGGCTTTCAACAGTAACGTAATGTTACTTTCTCAT
GCAATCTTAGCATTTTGGTTAATCCTCCAGACTCGAGATTTTGCGTTAACAAATTACGACCCGGAAGCAG
GCAGAAGATTTTACGAGTTCATGTGGAAGCTTTATTATGCTGAATATTTAGTATATGTTTTCATATAA(配列番号7)
ATGGCAGTGAAGCATTTGATTGTATTGAAGTTCAAAGATGAAATCACAGAAGCCCAAAAGGAAGAATTTT
TCAAGACGTATGTGAATCTTGTGAATATCATCCCAGCCATGAAAGATGTATACTGGGGTAAAGATGTGAC
TCAAAAGAATAAGGAAGAAGGGTACACTCACATAGTTGAGGTAACATTTGAGAGTGTGGAGACTATTCAG
GACTACATTATTCATCCTGCCCATGTTGGATTTGGAGATGTCTATCGTTCTTTCTGGGAAAAACTTCTCA
TTTTTGACTACACACCACGAAAGTAG(配列番号8)
ATGAATCATCTTCGTGCTGAGGGTCCGGCCTCCGTTCTCGCCATTGGCACCGCCAATCCGGAGAACATTT
TATTACAAGATGAGTTTCCTGACTACTATTTTCGCGTCACCAAAAGTGAACACATGACTCAACTCAAAGA
AAAGTTTCGAAAAATATGTGACAAAAGTATGATAAGGAAACGTAACTGTTTCTTAAATGAAGAACACCTA
AAGCAAAACCCAAGATTGGTGGAGCACGAGATGCAAACTCTGGATGCACGTCAAGACATGTTGGTAGTTG
AGGTTCCAAAACTTGGGAAGGATGCTTGTGCAAAGGCCATCAAAGAATGGGGTCAACCCAAGTCTAAAAT
CACTCATTTAATCTTCACTAGCGCATCAACCACTGACATGCCCGGTGCAGACTACCATTGCGCTAAGCTT
CTCGGACTGAGTCCCTCAGTGAAGCGTGTGATGATGTATCAACTAGGCTGTTATGGTGGTGGAACCGTTC
TACGCATTGCCAAGGACATAGCAGAGAATAACAAAGGCGCACGAGTTCTCGCCGTGTGTTGTGACATAAT
GGCTTGCTTGTTTCGTGGGCCTTCAGAGTCTGACCTCGAATTACTAGTGGGACAAGCTATCTTTGGTGAT
GGGGCTGCTGCGGTGATTGTTGGAGCTGAACCCGATGAGTCAGTTGGGGAAAGGCCGATATTTGAGTTGG
TGTCAACTGGGCAAACAATCTTACCAAACTCGGAAGGAACTATTGGGGGACATATAAGGGAAGCAGGACT
GATATTTGATTTACATAAGGATGTGCCTATGTTGATCTCTAATAATATTGAGAAATGTTTGATTGAGGCA
TTTACTCCTATTGGGATTAGTGATTGGAACTCCATATTTTGGATTACACACCCAGGTGGGAAAGCTATTT
TGGACAAAGTGGAGGAGAAGTTGCATCTAAAGAGTGATAAGTTTGTGGATTCACGTCATGTGCTGAGTGA
GCATGGGAATATGTCTAGCTCAACTGTCTTGTTTGTTATGGATGAGTTGAGGAAGAGGTCGTTGGAGGAA
GGGAAGTCTACCACTGGAGATGGATTTGAGTGGGGTGTTCTTTTTGGGTTTGGACCAGGTTTGACTGTCG
AAAGAGTGGTCGTGCGTAGTGTTCCCATCAAATATTAA(配列番号9)
ATGGGTAAGAATTACAAGTCCCTGGACTCTGTTGTGGCCTCTGACTTCATAGCCCTAGGTATCACCTCTG
AAGTTGCTGAGACACTCCATGGTAGACTGGCCGAGATCGTGTGTAATTATGGCGCTGCCACTCCCCAAAC
ATGGATCAATATTGCCAACCATATTCTGTCGCCTGACCTCCCCTTCTCCCTGCACCAGATGCTCTTCTAT
GGTTGCTATAAAGACTTTGGACCTGCCCCTCCTGCTTGGATACCCGACCCGGAGAAAGTAAAGTCCACCA
ATCTGGGCGCACTTTTGGAGAAGCGAGGAAAAGAGTTTTTGGGAGTCAAGTATAAGGATCCCATTTCAAG
CTTTTCTCATTTCCAAGAATTTTCTGTAAGAAACCCTGAGGTGTATTGGAGAACAGTACTAATGGATGAG
ATGAAGATAAGTTTTTCAAAGGATCCAGAATGTATATTGCGTAGAGATGATGACATTAATAATCCAGGGG
GTAGTGAATGGCTTCCAGGAGGTTATCTTAACTCAGCAAAGAATTGCTTGAATGTAAATAGTAACAAGAA
ATTGAATGATACAATGATTGTATGGCGTGATGAAGGAAATGATGATTTGCCTCTAAACAAATTGACACTT
GACCAATTGCGTAAACGTGTTTGGTTAGTTGGTTATGCACTTGAAGAAATGGGTTTGGAGAAGGGTTGTG
CAATTGCAATTGATATGCCAATGCATGTGGATGCTGTGGTTATCTATCTAGCTATTGTTCTTGCGGGATA
TGTAGTTGTTTCTATTGCTGATAGTTTTTCTGCTCCTGAAATATCAACAAGACTTCGACTATCAAAAGCA
AAAGCCATTTTTACACAGGATCATATTATTCGTGGGAAGAAGCGTATTCCCTTATACAGTAGAGTTGTGG
AAGCCAAGTCTCCCATGGCCATTGTTATTCCTTGTAGTGGCTCTAATATTGGTGCAGAATTGCGTGATGG
CGATATTTCTTGGGATTACTTTCTAGAAAGAGCAAAAGAGTTTAAAAATTGTGAATTTACTGCTAGAGAA
CAACCAGTTGATGCCTATACAAACATCCTCTTCTCATCTGGAACAACAGGGGAGCCAAAGGCAATTCCAT
GGACTCAAGCAACTCCTTTAAAAGCAGCTGCAGATGGGTGGAGCCATTTGGACATTAGGAAAGGTGATGT
CATTGTTTGGCCCACTAATCTTGGTTGGATGATGGGTCCTTGGCTGGTCTATGCTTCACTCCTTAATGGG
GCTTCTATTGCCTTGTATAATGGATCACCACTTGTTTCTGGCTTTGCCAAATTTGTGCAGGATGCTAAAG
TAACAATGCTAGGTGTGGTCCCTAGTATTGTTCGATCATGGAAAAGTACCAATTGTGTTAGTGGCTATGA
TTGGTCCACCATCCGTTGCTTTTCCTCTTCTGGTGAAGCATCTAATGTAGATGAATACCTATGGTTGATG
GGGAGAGCAAACTACAAGCCTGTTATCGAAATGTGTGGTGGCACAGAAATTGGTGGTGCATTTTCTGCTG
GCTCTTTCTTACAAGCTCAATCATTATCTTCATTTAGTTCACAATGTATGGGTTGCACTTTATACATACT
TGACAAGAATGGTTATCCAATGCCTAAAAACAAACCAGGAATTGGTGAATTAGCGCTTGGTCCAGTCATG
TTTGGAGCATCGAAGACTCTGTTGAATGGTAATCACCATGATGTTTATTTTAAGGGAATGCCTACATTGA
ATGGAGAGGTTTTAAGGAGGCATGGGGACATTTTTGAGCTTACATCTAATGGTTATTATCATGCACATGG
TCGTGCAGATGATACAATGAATATTGGAGGCATCAAGATTAGTTCCATAGAGATTGAACGAGTTTGTAAT
GAAGTTGATGACAGAGTTTTCGAGACAACTGCTATTGGAGTGCCACCTTTGGGCGGTGGACCTGAGCAAT
TAGTAATTTTCTTTGTATTAAAAGATTCAAATGATACAACTATTGACTTAAATCAATTGAGGTTATCTTT
CAACTTGGGTTTACAGAAGAAACTAAATCCTCTGTTCAAGGTCACTCGTGTTGTGCCTCTTTCATCACTT
CCGAGAACAGCAACCAACAAGATCATGAGAAGGGTTTTGCGCCAACAATTTTCTCACTTTGAATGA(配列番号10)
ATGGAGAAATCTGGGTATGGAAGAGACGGTATTTACAGGTCTCTGAGACCACCTCTACACCTCCCCAACA
ACAACAACCTCTCAATGGTTTCATTCCTTTTCAGAAACTCATCTTCATACCCACAAAAGCCAGCTCTCAT
TGATTCCGAAACCAACCAAATACTCTCCTTTTCCCACTTCAAATCTACGGTTATCAAGGTCTCCCATGGC
TTTCTCAATCTGGGTATCAAGAAAAACGACGTCGTTCTCATCTACGCCCCTAATTCTATCCACTTCCCTG
TTTGTTTCCTTGGAATTATAGCCTCTGGAGCCATTGCCACTACCTCAAATCCTCTCTACACAGTTTCCGA
GCTTTCCAAACAGGTCAAGGATTCCAATCCCAAACTCATTATCACCGTTCCTCAACTCTTGGAAAAAGTA
AAGGGTTTCAATCTCCCCACGATTCTAATTGGTCCTGATTCTGAACAAGAATCTTCTAGTGATAAAGTAA
TGACCTTTAACGATTTGGTCAACTTAGGTGGGTCGTCTGGCTCAGAATTTCCAATTGTTGATGATTTTAA
GCAGAGTGACACTGCTGCGCTATTGTACTCATCTGGCACAACGGGAATGAGTAAAGGTGTGGTTTTGACT
CACAAAAACTTCATTGCCTCTTCTTTAATGGTGACAATGGAGCAAGACCTAGTTGGAGAGATGGATAATG
TGTTTCTATGCTTTTTGCCAATGTTTCATGTATTTGGTTTGGCTATCATCACCTATGCTCAGTTGCAGAG
AGGAAACACTGTTATTTCAATGGCGAGATTTGACCTTGAGAAGATGTTAAAAGATGTGGAAAAGTATAAA
GTTACCCATTTGTGGGTTGTGCCTCCTGTGATACTGGCTCTGAGTAAGAACAGTTTGGTGAAGAAGTTTA
ATCTTTCTTCTATAAAGTATATTGGCTCTGGTGCAGCTCCTTTGGGCAAAGATTTAATGGAGGAGTGCTC
TAAGGTTGTTCCTTATGGTATTGTTGCTCAGGGATATGGTATGACAGAAACTTGTGGGATTGTATCCATG
GAGGATATAAGAGGAGGTAAACGAAATAGTGGTTCAGCTGGAATGCTGGCATCTGGAGTAGAAGCCCAGA
TAGTTAGTGTAGATACACTGAAGCCCTTACCTCCTAATCAATTGGGGGAGATATGGGTGAAGGGGCCTAA
TATGATGCAAGGTTACTTCAATAACCCACAGGCAACCAAGTTGACTATAGATAAGAAAGGTTGGGTACAT
ACTGGTGATCTTGGATATTTTGATGAAGATGGACATCTTTATGTTGTTGACCGTATAAAAGAGCTCATCA
AATATAAAGGATTTCAGGTTGCTCCTGCTGAGCTTGAAGGATTGCTTGTTTCTCACCCTGAAATACTCGA
TGCTGTTGTGATCCCATTTCCTGATGCTGAAGCGGGTGAAGTCCCAGTTGCTTATGTTGTGCGCTCTCCC
AACAGTTCATTAACCGAAAATGATGTGAAGAAATTTATCGCGGGCCAGGTTGCATCTTTCAAAAGATTGA
GAAAAGTAACATTTATAAACAGTGTCCCGAAATCTGCTTCGGGGAAAATCCTCAGAAGAGAACTCATTCA
GAAAGTACGCTCCAACATGTGA(配列番号11)
ATGTCTTTTATGATGAGCATGAATCCTTCTCCCTCCTCGCCACCGCCACCGTTATCGTCGCCGTCGGAAT
CTTCCTCAACGCCGTCAACACTGCCAGTCCGTACGATCCCGGGAAGCTACGGATGGCCGTTACTGGGGCC
CATCTCGGACCGGTTAGACTACTTCTGGTTCCAAGGCCCAGATACGTTTTTCAGAAAAAGAGTAGAGAAA
TACAAGAGCACAGTGTTCCGTACCAACATACCCCCGACCTTTCCTTTCTTCAGCGTTAATCCGAACATTG
TGGCCGTGCTGGACTGTAAATCATTTTCTCATCTTTTCGACATGGAAATTGTCGAGAAAAAGAATGTTCT
TGTTGGAGATTTCATGCCCAGTGTCAATTACACTGGTGATATTAGGGTTGGAGCTTATCTCGACACTTCT
GAACCACAACACGCTAAGGTTAAGAACTTCGCAATGGATGTACTAAAACAAAGCTCGAAGATATGGGTGG
GAGAACTGACATCAAATCTGTCGACGATGTGGGACACAATAGAAAAAGACGTATCTGAGAAATCATCCTC
ATCCTACTTAGCCCCACTTCAAAAGTTCTTGTTCAACTTCCTGGTCAAGTGTCTAATTGGTGCTGACCCT
TCCAACTCCCCCAAGATTGCAGAGTCTGGCTACATCATGCTCGACCGATGGTTAGCCTTCCAGCTCCTTC
CCACTATCAAGATTGGGATCCTTCAGCCTCTTGAGGAGCTTTTCATTCACTCTTTTGCCTATCCTTTTTT
CTTGGTCAGTGGTGACTACAATAACCTCTCCAGTTTTGTAGAGGAATATGGTAAAGAAATAGTAGCGAGA
GGTGAAACCGAGTTCGGGCTGAGTAAACAAGAAGCGATTCACAACCTTCTCTTCATTTTGGGTTTCAACG
CCTTCGGGGGATTCTCTATATTTCTACCGAGCCTACTGGGCACCGTGGCGAGTGACACAACCGATCTACA
ACAAAGACTGGTCAAAGAAGTCAGACAAAATGGCGGGTCAACTCTGACGTTTGACTCGATCAAAGAAATG
CCACTCGTTCAATCGGTCGTGTACGAGACTCTCCGGCTCAATCCACCTGTTCCGCTCCAATTCGCCAGGG
CCAGGAAGGACTTCCGGCTCAGCTCGCACGACGCGGCCTTCGAGGTGAAGAAAGGCGAGCTCCTATGCGG
GTTTCAAAGCCTTGTTATGAGGGACCCAAAAATATTCTCGGAACCGGAGTCGTTCATTGGGGACCGGTTC
ATGAAAGATAAAGGTCTCTTAGATTATCTTTACTGGTCCAATGGACCTCAAACCGGTGTGCCCAGCGTCA
CCAATAAGCAATGCGCGGGAAAAGATATCGTCACGCTTACGGCTTGTTTGATCTTGGCTTACACCTTCCG
TCGTTATGACTCCATCAGCGGGAGCTCAAGTTCAATCACAGCCCTTAAAAAGGCTTAA(配列番号12)
ATGTTGAAGCCTCCTCATCAAGTAGTTCAAAATTTGAAATATGAGAAAACCCTAGTTCTTTTGAACAAGC
CATTCATCCATGGCTACAACGGGGCTATTATCGGTGTCAACTCTCGGCTATTTCCAGTAAAACCTAAAAC
CAAAAGACGAGTCGCTTCATCATCATCATCATCATCTCCCGGAACCAAAAACATTATTAAAGCTTCTTTA
TTTTCTCCAATGGAGAAGAAGAATACAGCTAGGGTTTCGGTTAGTGTGGCGGTACAACGTGTGACTCCAA
AGTTTTGGAGATTTGAATTGTCTGAGAAAATCCAAGATGGACGTGATAGGCTTGAGGATCTTCTAGGGCT
AAACTCTTTAAGTATTGAGCTTGTTAGTACTCAAAAAGATCCAGTAACGGGGAAAGAGCGAACGGTTAAA
GGTTTTCCAAAAAGGCCCAACTTTAACATATTTTCATCAAGTGATGTAAAATACGAAGCGAAATTTGACA
TACCAAAAGATTTTGGAGAAGTGGGTGCTATAATCGTCGAAAATGATTTTGAAAGAGAAATATTTTTAAA
GAATATTATACTCGAAGACTTGCCCTCCGAACCAAGCACCCTTGAATTCTCTTGCAACTCGTGGGTTCAG
TCCAAACATGATGTCCCTACTGATCAACACAAGAGAGTCTTCTTCTCTAATAAGTGTTACCTACCATCAC
AAACACCAAGTGGGATAAAAGAATTGAGAAAAATTGCATTGGAAAATTTGAGAGGAGATGGAAAAGGAGA
GAGGAAGAAGAATGAAAGAGTTTATGATTATGATGTGTATAATGATCTTGGACAACCGGACAACAATGAT
GACCTAAAAAGACCTATTCTTGGCGGATCAAAAGAATTCCCTTATCCTAGGCGTTGTAGAACCGGACGGC
CTCCAACTGAAACTGATCCATTATCTGAGTCAAGGATTAGTGATTTTTATGTACCAAGAGATGAAGAATT
TGCAGAAGTGAAGCAAAGTAATTTTAGTTTGAAGACTGTATACTCAGTAATACATGCAGTGATTCCCATA
CTCAGACAAGTCTTAATTGATGAAAATTTCCCATACTTCACTGCCATTGATGTTCTCTATGATGAAGGCA
TTAAAATCCCTTCTAATGCTGAAAAGACCTTAATTCAAACCATCAAAAATGTCAATGCAAGAATATACAA
AACTGTTTCTGATGCTGATGATTTTTTACAGTTTCAGCAGCCTCCAACCATGGACAAGGACAAATTCTTC
TGGTTTAGAGATGAAGAGTTTTGTAGACAAACTATTGCCGGTCTCAACCCTTGCTGCATTGAATTGGTTA
AGGAGTGGCCTTTGAAAAGTGAACTTGACCCCACAATCTATGGCCCACCAGAGTCAAAAATCACCACAGA
ATTGGTTGAGAAATTCATCAAAGTATATGGCTACAATAATATTAATGAGGCTTTAAAAGAAAAAAAATTG
TTCATGTTGGATTACCATGATGTATTATTACCATATGTTAGCAAAGTAAGGGAACTGGAAAATAAAACCT
TGTATGGATCAAGAACACTTTTTTTCTTGACTCCTTATGGTACATTGTTGCCTTTGGCCATTGAATTGAT
TCGGCCACCGATGGATGGTAAGCCGCAATGGAAGGAAGTCTACACCCCGATGAATTGGCATTCTACCGAT
CTTTGGCTTTGGAGACTCGCAAAAGCTCATGTCCTTGCTCATGATTCCGGTGTTCATCAACTCGTTAGTC
ACTGGCTAAGAACACATTGTGCAGTTGAGCCATATATAATTGCAACAAATAGACAATTGAGTGCAATGCA
TCCTATCCATAGATTATTGAAGCCACATTTTAGATACACAATGGAGATTAATGCTCTTGCTCGAGAAAGT
TTGATCAATGCAGGTGGTATCATCGAAACAGCATTTGCACCTGGAAAATATTCTATGGAGTTAAGCTCCG
TCATGTACGACAAACAATGGCGATTCGATCTACAAGCATTGCCAGCTGACCTAATTCATAGAGGAATGGC
TGTTGAGGACAAGGATAGTGAACATGGTGTAAGAGTAATAATTGAAGATTACCCTTACGCCAACGACGGT
CTTCTCATATGGAGCTCCATCAAACAATGGGTTACTGACTACGTCAACCACTACTACCCTACCTCCAGTG
AGGTAGAGCGCGACGAAGAATTACAAGCATGGTGGACAGAGATCAGAACTGTAGGTCACGCTGACAAGAA
AGACGCACCTGGGTGGCCTGACTTAAAAACGAAACAAGATCTCATAGACATTGTCACAAACATGGCATGG
ACAGCATCAGCTCACCATGCAGCTGTCAACTTTGGACAATATGCTTACGCTGGCTATTTCCCTAACCGAC
CAACCATAACAAGAACTGTTATGCCGTCAGAAGAGAAGGAGTATAACCTAGATGCGTGGAAACACTTCAA
AAATAGTCCTGAAGACGCCCTTTTGAAGTGCTTACCTACGCAATTACAAGCAGGCCTAGTTGTGGCCGTG
TTAGACGTGTTGTCTACTCACTCGCCAGACGAAGAGTATCTTGGAGACAAGATGGAACCCTCGTGGGGCT
CGAATCTTGTTATAGCGGAAGCTTTTAATCGGTTCAATAAGAGGATGAACGAGATTGAAAGTATCATTAA
TGAAAAGAATGATAATGAGAATTTAAGGAATAGACATGGAGCTGGAATTTTGTCTTATGAACTTCTCAAG
CCCTTTTCTGAGCCTGGTGTCACTAACAAGGGTATTCCATATAGCATATCTATTTGA(配列番号13)
ATGGGAGCCGGTGGCAAAAATAGTAGACTTGAGCGAGCACCACACACCACACCACCATTCACACTAAGCC
AACTCAAGAAAGCCATTCCACCCCATTGCTTCAACCATTCTCTTCTTCGTTCCTTCTCTCATGTCCTTCA
AGACCTTTTTTTCTCCTTTTTGTTCTACTACATAGCAACCTCTTACTTCCATCTTCTCCCACACCCGCTC
CAATACTTAGCTTGGCCACTTTATTGGATCTTCCAAGGCAGCATTTTTGCTGGTATTTGGGTCCTTGGTC
ATGATTGTGGTCACCAAGCTTTCAGTGACCACCAATGGGTGGATGACACcGTTGGCTTTGTCCTCCACTC
CGCTCTTCTCTTCCCATACTTCTCTTTTAAGTATAGTCATCGTCGCCATCATTCAAACATCGGCTCCCTT
GAACATGATCAATTGTTTGTTCCAGTCCCCGAATCTCAAATCGCATGGCTCTACAAACgTTACTTGGACA
ATCCACTAGGAAGAGCCCTAAAGCTTTCCACTATAGTGTTCCTTGGTTtTCCTTTGTACTTAGGTTTCAA
TCTTACAGGCAAACcATATGATCGTTaTGCATGTCATTATGATCCTTACTCTCCACTCTACTCAAAAAGT
GAAAGGCTTCATATATTGATTTCAGATATCGGTGTTTTCATCACCACATTaGTGTTATACCAGCTTGGCT
CGACTAAAGGgTTGAGTTGGCTTGTGTTCATGTATGGGGTGCCATTGTTTACAGGGAATAGCATCCTTGT
GACAATCGCATACTTGAATCATACTCACCCTTCATTGCCTCATTATGACTCGTCaGAGTGGGATTGGTTG
AAAGGAGCATTGTCAACAACTGATCGAAACTATGGATCAATTCTCAATAGGGTTTTCCATCACCTTACAG
ATGCTCATATGGCACACCATTTATTCGCAACAATACCTCACTACCATGCAAATGAAGCCACCAAAGTTAT
CAAATCCATATTGGGAGAATACTACTCTTTTGATGATACTCCAATAATTAAAGCTCTTTGGAGAGAGACT
AAGGAGTGTGTCTATATTGAGCCAAATCATGAATCTTCTCCTAATAATAACAAAGGTGTTTTCTGGTACA
ACAACAAGTTCTGA(配列番号14)
ATGAGCACTGTAAATCTCACATGGGTTCAAACCTGTTCCATGTTCAACCAAGGAGGTAGATCCAGATCCT
TATCAACTTTCAATCTCAATCTCTACCACCCTTTGAAAAAAACACCCTTTTCAATCCAAACCCCAAAACA
AAAACGACCCACTTCACCATTTTCATCAATCTCAGCTGTTCTAACCGAGCAAGAAGCCGTTAAAGAAGGC
GATGAAGAAAAATCCATCTTCAATTTCAAGTCTTACATGGTCCAAAAAGCCAACTCAGTCAACCAAGCTT
TAGACTCAGCCGTTTTGCTCAGAGATCCCATTATGATACACGAGTCCATGCGTTACTCACTCCTCGCCGG
AGGAAAACGAGTCAGACCCATGCTCTGTCTCTCAGCCTGTGAACTCGTAGGCGGAAAAGAATCCGTAGCC
ATGCCGGCTGCCTGCGCCGTCGAAATGATCCACACCATGTCTCTAATCCACGACGACCTCCCTTGTATGG
ACAACGATGACCTCCGCCGTGGAAAGCCCACAAACCACAAAGTCTTCGGAGAAGACGTGGCCGTTTTAGC
CGGCGATGCACTTTTAGCCTTTGCTTTTGAGCACATGGCGGTCTCTACCGTTGGTGTTCCGGCAGCCAAG
ATTGTCAGGGCGATTGGTGAGCTTGCTAAGTCAATTGGGTCAGAAGGATTAGTGGCTGGTCAAGTGGTTG
ATATTGATTCAGAGGGTTTGGCTAATGTTGGGCTTGAACAACTTGAGTTCATTCATCTCCATAAGACTGG
GGCTCTTCTAGAAGCTTCTGTTGTTTTGGGGGCTATTCTTGGTGGTGGTACAGATGAAGAAGTTGAAAAA
CTTAGGAGCTTTGCTAGGTGTATTGGCTTGCTTTTTCAGGTTGTTGATGACATTCTTGATGTGACTAAAT
CTTCTCAAGAATTGGGTAAAACTGCTGGGAAAGATTTGGTGGCTGATAAGGTTACTTATCCAAGGCTAAT
GGGTATTGACAAATCAAGAGAATTTGCTGAGCAATTGAACACAGAAGCCAAACAGCATCTTTCTGGTTTT
GATCCCATAAAGGCTGCTCCTTTAATTGCTTTGGCTAATTATATTGCTTATAGGCAAAATTGA(配列番号15)
ATGGCGGTTTATAATCTATCAATTAATTGCAGTCCAAGATTTGTTCATCATGTTTACGTTCCACATTTCA
CATGTAAATCCAATAAGTCGTTAAGTCACGTACCCATGAGAATAACCATGTCCAAACAGCATCATCATTC
TTATTTTGCCTCCACAACAGCCGATGTAGATGCCCATCTCAAGCAATCCATCACTATCAAGCCACCACTC
TCAGTTCACGAGGCCATGTACAATTTCATCTTTTCCACACCTCCGAATTTAGCACCGTCATTGTGCGTGG
CGGCGTGTGAGCTTGTCGGGGGCCACCAGGACCAGGCCATGGCAGCAGCCTCCGCCTTGCGCGTCATCCA
CGCAGCCATCTTCACTCATGACCACCTCCCTTTAACGGGCAGGCCCAATCCAACAAGTCCTGAGGCAGCG
ACCCACAATTCTTACAACCCAAATATTCAGCTCCTTCTCCCGGACGCAATTGTACCTTTTGGGTTCGAAT
TGTTGGCCAATTCTGATGACCTTACCCATAATAAATCAGATCGGATTTTGCGGGTCATTGTAGAGTTCAC
ACGCACCTTTGGATCACGAGGAACTATTGATGCTCAATACCATGAGAAGCTAGCCAGTAGATTTGACGTT
GATAGTCATGAAGCCAAAACTGTCGGGTGGGGCCATTATCCCTCTTTGAAGAAGGAAGGTGCGATGCATG
CATGCGCTGCTGCATGTGGGGCCATTCTTGGAGAGGCACATGAAGAAGAGGTTGAGAAGTTGAGAACTTT
TGGTCTTTATGTGGGCATGATTCAAGGATATGCCAATAGATTTATAATGAGCAGCACAGAAGAAAAGAAA
GAAGCAGATAGAATCATCGAGGAGTTAACCAATTTGGCTCGCCAGGAACTAAAATATTTCGATGGGAGAA
ACTTAGAGCCATTTTCAACCTTTCTTTTTCGTCTATAG(配列番号16)
ATGGGAGACTCTGCCGACGCTGGAATGGACGCTGTCCAGAGACGCCTTATGTTTGATGATGAATGCATTC
TAGTGGATGAGAATGACCGAGTTGTTGGTCATGATACAAAATATAACTGTCACTTGATGGAAAAGATTGA
AAAGGATAATTTGCTACACAGGGCTTTCAGTGTGTTCTTGTTCAACTCAAAATATGAGTTGCTTCTTCAG
CAACGTTCTGCAACAAAGGTAACATTCCCTCTTGTGTGGACAAACACCTGTTGTAGCCACCCGCTCTACC
GTGAATCTGAGCTTATCGATGAGGAGTCCCTTGGAGCAAGGAATGCAGCACAGAGAAAGCTTTTAGATGA
GCTGGGTATTCCTGCTGAAGATGTGCCAGTTGATCAATTTACCCCACTAGGCAGGATGCTGTACAAAGCT
CCTTCTGATGGCAAATGGGGCGAGCATGAACTTGATTACCTGCTCTTCATCGTCCGGGATGTTAGTGTCA
ATCCAAATCCAGATGAAGTAGCTGATATCAAGTATGTAAACCGGGACGAGTTGAAAGAGTTGTTGAGGAA
AGCAGATGCTGGGGAAGGAGGCTTGAAGCTATCCCCTTGGTTCAGACTGGTTGTGGATAATTTCTTGTTC
AAGTGGTGGGACCATGTTGAGAAAGGCACACTTAAGGAAGTTGCTGATATGAAAACCATTCACAAGTTGA
CTTAA(配列番号17)
ATGGCGTTTTGTGCATTATCATTTCCTGCTCATATTAGCCGGGCAACTACACCAGCACCTTCAGATCTTC
ACAAATCTAGTTCTTTCTCTTCTCGGTTTTATTGGGGAGCAGATCTGCTGAGGCCATCTCAATACAAGGT
CAGGAAAATACAAAGTGGGGTTTATGCATCACTGTCAGAAAGTGGAGAATATCACTCAAGGAGACCACCA
ACTCCTCTCTTGGACACCATAAATTATCCAATTCATATGAAAAATCTCTCTGTTAAGGAGCTTAAACAAC
TATCAGATGAACTAAGGTCTGATGTCATCTTCAACGTTTCTAACACCGGGGGTCACCTGGGCTCAAGCCT
TGGTGTTGTTGAGCTTACTGTGGCTCTTCATTTTGTCTTCAATACTCCTCAGGATAGGATACTATGGGAT
GTTGGTCATCAGTCTTACCCTCATAAAATTCTGACTGGAAGAAGAGATAAGATGCACACCATGAGGCAGA
CCAACGGGTTAGCCGGATTCACTAAGCGGTCTGAGAGTGAATATGATTGTTTTGGGACTGGTCATAGTTC
TACCACCATCTCAGCTGGCTTGGGAATGGCTGTTGGAAGGGATCTTAAAGGAAGAAAGAATAATGTTGTG
GCTGTCATAGGTGATGGTGCCATGACAGCAGGTCAAGCTTATGAAGCCATGAATAATGCCGGGTACCTTG
ATTCCGACATGATTATTATTCTTAACGACAATAAACAGGTTTCTTTACCTACTGCCTCTCTTGATGGGCC
CATACCACCTGTTGGAGCTTTGAGTAGTGCTCTCAGTAGGCTGCAATCAAACAGGCCTCTTAGAGAACTA
AGAGAAGTAGCCAAGGGAGTTACTAAACAAATAGGTGGATCAGTACATGAATTGGCTGCAAAAGTTGATG
AATATGCTCGTGGAATGATAAGTGGTTCTGGCTCAACATTGTTTGAGGAGCTTGGACTCTATTATATTGG
TCCAGTTGATGGTCACAATATAGATGATCTTGTTTCCATACTAGAGGAGGTTAAGAGCACTAAAACAACA
GGTCCAGTCTTGATCCATTGCATCACTGAGAAAGGAAGAGGATATCCATATGCAGAGAAAGCTGCTGATA
AGTATCATGGGGTGGCCAAGTTTGATCCAGCAACTGGAAAGCAATTCAAAGGCACTTCTAACACACAGTC
ATACACTACATACTTTGCTGAGGCTTTGGTTGCAGAAGCAGAGGCAGACAAAGATGTTGTGGCCATCCAT
GCTGCAATGGGTGGTGGAACAGGCTTGAATCTCTTCCTTCGCCGTTTTCCAACAAGATGTTTTGATGTTG
GGATAGCAGAACAGCATGCTGTTACTTTCGCTGCTGGTTTGGCTTGCGAGGGCCTTAAGCCGTTTTGTGC
AATTTACTCATCTTTCATGCAGCGAGCCTATGATCAGGTAGTACATGATGTTGATTTGCAGAAGTTGCCG
GTGAGATTTGCAATGGACAGAGCTGGACTTGTTGGGGCCGACGGCCCTACACATTGTGGTGCTTTTGATG
TTACTTTCATGGCATGCCTCCCAAACATGGTTGTGATGGCTCCTTCCGATGAGGCAGAGCTCTTCCACAT
GGTTGCCACCGCTGCTGCCATAGATGACAGACCAAGTTGTTTCCGTTACCCCAGAGGAAATGGAATTGGT
GTTCCATTACCTCAAGGGAATAAAGGAACTCCTCTTGAGATCGGAAAAGGCAGGGTATTGGTTGAAGGGG
AAAGAGTAGCACTTCTAGGCTATGGAACAGCAGTTCAGAGTTGTTTGGCTGCTGCAGCCTTAGTAGAACC
TCACGGTCTACGGCTAACAGTTGCTGATGCACGATTTTGCAAGCCTTTGGATCATGCCCTCATTCGCGAA
CTAGCGAAAAATCACGAGGTTTTGATTACAGTGGAAGAAGGATCTATAGGAGGTTTTGGATCTCATGTTG
CTCAGTTTATGGCCCTTGATGGCCTTCTTGATGGAAAAACAAAGTGGAGACCAATTGTTCTTCCTGACCG
ATACATCGACCACGGTTCGCCTGCTGATCAATATGTCGACGCGGGTCTCACGCCACCTCACATTGCAGCC
ACAGTTTTCAATGTACTAGGACAAACAAGAGAGGCCTTGAAGGTTATGACAACATGA(配列番号18)
ATGGCGGTTTCTGGTTCATTCATTGTACCAAATCATTCATTCCTTTCACAACTTAAATCTCCACAGCCAT
ATTACAGTTCCAACAAACAGTTGAGTTTAAGGGTGAGAGGATCTCTTTGTAGCTCAGATGATGGGGAAGG
AAAATTCATCAGCAAAGAAAAAGATGAATGGAAAATCAAGTATTCCAGTGAAAAACCAATCACTCCATTG
CTTGATACAGTCAATTACCCAGTTCACATGAAGAATTTATCCACACAGGATCTTGAACAGCTAGCAGCAG
AGCTTAGAGCAGATGTAGTCCATACAGTATCAAAAACAGGTGGTCATCTGAGTGCAAGCTTGGGAGTTGT
GGAGCTCACTGTAGCACTGCATCATGTTTTCAATACCCCTGATGATAAAATCATATGGGATGTTGGACAT
CAGACATACCCGCATAAGATTCTTACAGGAAGGAGGTCTCAAATGCATACCATTAGAAAGACTTCTGGTC
TAGCAGGGTTTCCCAAAAGAGATGAGAGTGTTTACGATGCTTTCGGTGCAGGTCACAGTTCTACAAGCAT
ATCAGCAGGCCTTGGCATGGCAGTTGCCAGGGATCTTCTGGGAAAGAAGAACAGTGTTGTTTCTGTGATT
GGAGATGGGGCCATGACTGCAGGAATGGCATATGAAGCCATGAATAATGCCGGCTACTTGGACGCCAACT
TGATTGTTGTATTAAACGACAATAAACAAGTTTCTTTACCAACTGCTACTCTTGATGGTCCTGCAACCCC
AGTGGGAGCTCTAAGTGGTGCTTTGACTAAGCTTCAAGCAAGCACCAAGTTCAGAAAACTTCGCGAAGCT
GCGAAAACCATCACAAAACAAATTGGAGGGCCAGCACATGAAGTTGCAGCTAAAGTAGATGAGTATGCTA
GAGGAATGATAAGTGCTTCTGGGTCAACACTCTTTGAGGAGCTTGGGTTGTATTATATTGGTCCGGTGGA
TGGACATAATGTTGGAGATTTAGTCACCATTTTTGAGAAAGTGAAATCAATGCCAGCGCCAGGACCAGTC
TTGATCCACATCGTCACAGAGAAAGGGAAAGGCTATCCCCCAGCTGAAGTAGCACCTGATAAAATGCATG
GAGTTGTAAAGTTTGACCCAACAACAGGAAAGCAATTTAAGTCCAAATCGTCGACACTTTCATATACTCA
ATACTTTGCTGAATCTCTAATAAAAGAAGCTGAAGAAGATGACAAGATTGTTGCCATACACGCAGCAATG
GGTGGTGGCACTGGTCTCAATTATTTCCAGAAGAAATTTCCTGATCGTTGCTTTGATGTGGGGATTGCTG
AGCAACATGCTGTCACGTTTGCAGCTGGATTAGCTGCAGAGGGTCTCAAACCATTCTGTGCCATATACTC
ATCATTCCTGCAACGAGGATATGATCAGGTTGCACATGATGTAGACCTTCAAAAATTACCTGTCCGTTTT
GCATTGGATAGAGCTGGCATGGTTGGCGCAGATGGGCCTACCCACTGCGGTGCATTTGATATCACCTACA
TGGCCTGCTTGCCCAACATGGTTGTCATGGCTCCATCAGATGAGGCTGAACTTATGCACATGGTGGCCAC
AGCAACAGCTATAGATGACAGACCCAGTTGCTTCAGGTTTCCAAGGGGCAATGGAATTGGAGCAAAGCTT
CCAGCTAATAATAAAGGAACTATACTTGAGATTGGAAAAGGCAGAATATTAATGGAAGGCAGCAGAGTAG
CTATTTTGGGTTATGGTTCTATTGTTCAGCAATGTGTGGAAGCTGCAAGCATATTAAAGAAACAAGACAT
TTCAGTGACAGTAGCTGATGCAAGATTTTGCAAACCATTGGATACAAATCTCATAAGACGGTTAGCCAAC
GAGCATGAAATCCTAATCACTGCCGAAGAAGGTTCTATTGGAGGCTTTGGGTCTCATGTGTCACACTTTC
TAAGCTTAAGTGGACTTCTTGATGGGTCTTTAAAGTTGAGAGCAATGGTTCTTCCTGATAGATACATTGA
CCATGGATCACCCCAAGATCAGACTGAAACAGCCGGGCTCTCCTCGAGGCATATATCTGCAACAGTCTTA
TCTCTCTTGGGGAAGCCCAAGGAAGCACTTCAGTTCATGTAA(配列番号19)
ATGGCTCTGAACTTGTTATCCCCAGCTGAAGTGAAGGCTCTATCCTTTTTGGACTCCACCAAGTCCACCC
GCTTCCCTAAGCTGTGTCCAGGTGGAATTACTTTGCATAGAAAGGATTGCAGAGTACCACTTAGAAGAAG
AGTTCATTGTTCGTTGCAGCAACCTCCTCCAGCTTGGCCAGGAAGAGCTATTCCAGAGCAAGATCTTTGT
AATTGGAATGTCCCAAAGCCTATATCTATTATTGGCTCTACTGGCTCTATAGGAACTCAGACACTGGACA
TTGTGGCAGAGAATCCAGATAAATTCAGAATAGTGGGACTTGCAGCTGGTTCGAATGTGACACTTCTTGC
AGACCAGGTGAAGAGATTCAAGCCTCAAATAGTTGCTCTTAGAAATGAATCATTAATTGGTGAACTAAAA
GAGGCCTTAGCTGATGTGGAAGAAATGCCCGAAATTATTCCTGGGGAACAAGGAGTAATTGAGGTTGCCC
GGCACCCAGATGCAGTCACAGTGGTTACAGGAATAGTAGGTTGTGCTGGATTACAGCCTACAGTTGCTGC
AATTGAGGCAGGTAAACACATAGCTTTAGCCAATAAAGAGACCCTGATTGCTGGAGGTCCATTCATCCTT
CCTCTAGCTCACAAGCATAACATAAAAATTCTTCCTGCCGATTCAGAACATTCGGCAATATTCCAGTGTA
TCCAGGGCTTGCCTGATGGTGCACTACGGCGTATCATTTTGACAGCATCTGGGGGAGCTTTCAGAGATTG
GCCGGTTGAAAAGCTAAAAGATGTTAAGGTTGCTGATGCTCTGAAACATCCAAACTGGCCGGGTATGGGA
AAGAAAGTCACTATTGATTCTGCTACCCTTTTCAACAAGGGTCTGGAAGTCATTGAAGCCCATTATCTAT
TCGGAGCAGACTATGACGATATTGACATTGTGATTCACCCAGAAGCTATTATACACTCTATGATTGAAAC
ACAGGATTCTTCTGTTCTGGCTCAGTTAGGGTGGCCTGACATGCATATACCGATTCTCTATACTATGTCA
TGGCCAGACAGAATATACTGTTCTGAAGTAACTTGGCCTCGACTTGATCTTTGCAAGCTTGGTTCGCTGA
CCTTTAGGAGTCCTGACAACCAGAAGTACCCATCCATAGATCTTGCCTATTCTGCTGGACGTGCTGGGGG
CACCATGACTGGAGTTCTCAGTGCAGCCAATGAGAAAGCTGTAGAGATGTTTATTGATGAGAAGATAAGT
TATCTTGAAATCTTCAAAGTTGTTGAGCTAACATGCGACAAGCATCGATCAGAGATGGTGACTTCACCTT
CTCTTGATGAAATTATCCACTATGACTCGTGGGCACGAGAGTATGCAACTACTAGTTTGAAGAGTTCTTC
CAGTCCAAGACCTGTTACAGCATGA(配列番号20)
ATGGCGTTACTTGCAATGGACCTTACTTTCTCTTCTGCTTCTCTTTCTTCTTCTTCCTACAATGCTGCTC
CTCTACTATTTCCTTCTATTCGCCCATCCTCTCAATCCATTGTTCGATTCCCAGTCCATGAGGTGGGATT
CAGGGGGAAATGCAGAATTTCCAAGATAAGGTTCGCTCGCTGCTCTGCAAATGTTGGCCAAAAGCCTGGT
GTTGTGGAAAAGAAAAGCGTTTCGGTGGTTCTTCTGGCAGGTGGGAAGGGTAAACGGATGGGGGCCAACA
TGCCAAAGCAGTATCTTCCACTTTTAGGGCAACCAATTGCACTGTATAGCTTCTACACTTTTTCTAAAAT
GATTGAAGTGACTGAAATTGTTGTAGTTTGTGATCCCTCTTACGAGGATATCTTTGAAGATTCCAAAGTC
AAGATCCATGTTGGACTTAAATTCGCTCTGCCTGGAAAGGAAAGACAGGATTCAGTTTATAGTGGACTTC
AGGCAATTGATCCAAACTCTAAGCTTGTGTGCATTCACGATTCTGCTAGACCTTTGGTAACAACAGAAGA
AGTTAAAAAGGTCATTGAAGATGGTTGGTTGCATGGAGCAGCTGTACTTGGTGTTCCTGTCAAAGCTACA
ATCAAAGAGGCAAACAATGCATCTTTTGTAACTAAAACGTTGGAGAGGAAAAAACTTTGGGAAATGCAGA
CACCCCAGGTGATCAAACCCGAGTTGCTCAAGGAAGGATTTGAGCTTGTAAATAGGGAAAATCTGGAAGT
GACTGATGATGTGTCTATAGTGGAACACCTTGGACATCCTGTATATATAACTGAAGGTGCTTACACCAAC
ATCAAGGTTACTACTCCAGATGATTTATTGCTTGCGGAGAGAGTATTGAGTATGAACTCTGTGAAGGCTG
TTGCATAA(配列番号21)
ATGGCTTCCTCTCATATTCTCTGCCACAACAACGTTTTTAATCTTTCTCCCAATCCTTTTAGGAACAGGG
GTCTCTCTTCCTTAAACTCAAATGGGTTTTGTTTTTTTGGTTCGAAATCTAGAATTTCGAGGCCTTCATC
TCTCAAAATTGTGGTTTCTGAAAGAAGACAAGTTGAGATAGTTTATGATGCTGATGAAAGGATAAACAAA
TTGGCTGATGTAGTGGACAAGGAAGCGCCTCTTTCTAGGCTCACTCTTTTCTCACCTTGCAAGATTAATG
TTTTCTTGAGAATAACTAGCAAAAGGGAAGATGGGTATCATGATTTGGCATCCCTCTTTCACGTGATAAG
TCTTGGAGATGTGCTTAAGTTCTCTTTGTCTCCTTCAACAAAGAAAGATTCTTTGTCAACGAATGCCTCT
GGGGTACCACTTGATGATAGAAATTTGATTATCAAGGCCCTTAATCTTTACCGAAAGAAAACTGGTACAA
ACAAATACTTTTGGATTCATCTTGACAAGAAAGTGCCCACTGGAGCAGGGCTAGGTGGTGGGAGCAGCAA
TGCTGCAACAGCCCTATGGGCAGCAAATCAGTTCAATGGTTGTCTTGTTACTGAAAAGGAATTGCAAGAA
TGGTCAAGTGAGATTGGTTCAGATGTTCCTTTCTTTTTCTCCCAAGGGGCAGCCTATTGTACAGGTCGAG
GTGAGGTTGTTCAGGATATTCTACCACCTGTACCATTAAACATTCCCATGGTTCTCATAAAGCCCCCAGA
AGCATGTTCAACAGCCGAAGTTTATAAGCGTTTTCGGTTGGATAAAACCAGTAATAGTGATCCTTTACAA
TTGCTCCACAAGATCTCAAGTGATGGAATAAGTCAAGATGTCTGCATCAATGACTTAGAACCTCCTGCCT
TTGAAGTTCTTCCATCTCTTAAGAGATTGAAACAGCGTATAATTGCAGCTAGTCGTGGACAATATGATGC
TGTTTTTATGTCTGGGAGTGGAAGCACCATTGTCGGGGTCGGTTCCCCAGATCCACCTCAGTTTATATAT
GATGATGAGGACTACAAGGATGTGTTTTTGTCAGAGGCCAACTTTCTGACTCGAGAAGCAAATGAATGGT
ACAAAGAACCTGCTTCAGCTAGCGCTTGTAGCCCTTCAGATGATTTCTCTCGTAATTTTTCCTCCTCTGT
CGAGTAA(配列番号22)
ATGGCGGCGGCGACGGCAACACCACTCTGTGCTTCAACTCTTCCACCACACTACTCCAATACCTCCCCCA
AATCATTCAATCACTCCCATTTCACAGTCGCAGTTCCCAGAAATCTCTTCTCATCGTCCTCAATTTCATC
TCTAAGACAATCGAAAACGACGCCGCTTTCGGCTCTGCCTTCTGTATCGGCCGCCGCGACCACCGCTTTG
AACGCTGAGCAAGCTCCGTCTGAGGTATCTGCTACTCCCTCAAAGGCTCTTCCTTTTCGGGTTGGTCATG
GGTTTGACCTTCATCGATTGGAGCCTGGGTATCCTTTGATAATTGGAGGTATTAATATACCTCATGAGAA
AGGTTGCGAAGCTCATTCTGATGGGGATGTTTTGCTTCATTGTGTAGTTGATGCTATTTTGGGTGCTTTG
GGGCTTCCTGATATTGGTCAAATTTTCCCTGATTCTGATCCCAAATGGAAAGGGGCTGCATCATCAGTTT
TCATCAAAGAAGCTGTGAGACTGATGCATGAGGCAGGTTATGAGCTTGGAAATTTAGATGCAACATTAAT
TCTTCAAAGACCAAAGTTAAGTCCACACAAGGAAGCTATCAGAGCCAACTTGTCTGAACTTCTAGGAGCT
GACCCTGCAGTTGTTAATCTGAAAGCGAAAACTCACGAAAAGGTCGATAGTCTCGGGGAAAATCGAAGCA
TCGCTGCTCACACTGTGGTTCTTCTTATGAAAAAATAG(配列番号23)
ATGGCTTCTGGAGCTGTACCAGCATCAATTTCATGTCTGAAAAGCAGAGACTCTGGCTTGAGCTTTGCTA
AAAGTTCTGATTTTGTGAGGCTTTCTGATTTAAAGAGGGTTGGTTCATCTAGAACAAGAGTTTCAGTTAT
CCGAAATTCGAATCCTGGTTCAGATATTGCTGAACTTCAGCCTGCATCAAAAGGAAGCCCTCTATTAGTT
CCTAGACAGAAGTACTGTGAATCCTTACACAAAACTGTTAGGAGGAAAACGCGAACTGTGATGGTGGGAA
ATGTGGCTCTTGGCAGTGAGCATCCCATAAGAATTCAAACGATGACGACAAATGATACCAAGGATGTTGC
TGGAACAGTTGAAGAGGTGATGAGAATAGCTGATAAGGGAGCTGATATTGTTCGGATAACAGTTCAGGGA
AGAAAAGAAGCAGATGCTTGTTTCGAAATAAAAAATTCACTTGTGCAGAAGAATTATAATATACCTCTTG
TGGCAGATATTCATTTTGCTCCCCCAGTTGCATTAAGAGTTGCTGAATGCTTCGATAAAATTCGTGTCAA
TCCTGGAAATTTCGCTGACAGACGGGCTCAGTTTGAGACGCTCGAGTACACAGACGACGACTATCAGAAA
GAACTTGAGCATATTGAGCAGGTTTTTTCTCCATTGGTTGAGAAATGTAAGAAATATGGTAGAGCAATGC
GTATCGGGACAAACCATGGGAGTCTTTCAGATCGTATCATGAGCTACTATGGAGATTCTCCAAGGGGAAT
GGTTGAATCTGCATTTGAGTTTGCAAGGATTTGCCGGAAGTTGGATTTCCATAATTTTGTGTTTTCGATG
AAAGCAAGCAACCCAGTTGTCATGGTTCAGGCGTATCGTCTACTTGTTGCTGAAATGTATGTCCAGGGCT
GGGACTATCCACTTCACTTGGGAGTTACTGAAGCGGGAGAAGGTGAGGATGGACGAATGAAATCTGCAAT
TGGCATCGGGACCCTTCTTCAGGATGGTTTGGGTGATACTATCAGGGTTTCACTCACCGAACCGCCCGAG
GAGGAGATTGATCCCTGCAGAAGGTTGGCCAATTTGGGTACAAAAGCAGCTGATCTTCAGCAAGGAGTGG
CTCCATTTGAAGAGAAGCACAGGCATTATTTTGATTTTCAACGACGAACTGGTCAACTGCCTCTACAGAA
GGAGGGCGATGAGGTTGACTATAGAGGTGCTCTGCACCGTGATGGTTCTGTTCTCATGTCAGTGTCTCTC
AATAACTTAAAGATGCCCGAGCTCCTATACAGGTCACTAGCAGCAAAGCTTGTCGTCGGGATGCCATTTA
AGGATCTGGCAACAGTAGACTCCATCTTATTGAGACAACTTCCACCTATTGACGATGACAACGCTCGATT
AGCTCTCAAAAGATTGATAGACATAAGTATGGGGGTCATAACTCCTTTGTCGGAGCAGCTAACAAAGCCA
TTGCCAAATGCTATGGTTTTGGTAAATCTTAAGGAGTTATCATCTGGTGCACACAAGCTTTTGCCAGAAG
GCACGCGTTTGGTTGTATCCTTGCGCGGTGATGAACCTTACGAAGAACTGGAGATTCTCAAAGGGGTTGA
TGATGTTGTTATGATTCTTCATGATCTTCCGTTCGATGAACATAAAATTAGCAGAGTCCACTCAGCAAGA
AGATTATTTGAGTATCTATCAGATAATTCTCTTAACTTTCCTGTAATACACCACATTCAATTTCCAAATG
GAATCCACAGGGATGACTTAGTCATCGGTGCAGGTAGCAACGCTGGTGCCCTTTTAGTAGATGGACTCGG
GGACGGTATCCTCTTAGAAGCCCCAGATCAGGATTTCGATTTTCTTAGAAATACTTCTTTCAACCTACTT
CAAGGTTGTAGAATGCGAAATACAAAGACGGAGTATGTCTCGTGCCCATCCTGCGGTAGAACTTTGTTTG
ACCTTCAAGAAATCAGCGCAGAGATTCGAGAGAAGACATCACACCTGCCCGGTGTCTCAATTGCAATCAT
GGGTTGCATTGTTAATGGACCCGGAGAGATGGCTGATGCAGACTTCGGTTATGTCGGTGGTGCTCCCGGA
AAGATTGACCTTTATGTTGGAAAGACGGTAGTGCAGCGTGGAATCGCAATGGAACAAGCGACCGATGCAT
TGATTCAGCTAATAAAAGATCATGGCCGATGGGTTGAACCACCCTCGGACGAAGAATGA(配列番号24)
ATGTCGATCACTTTCCAGCTCTGCCGGATTCCAATCCGTACCGACCTCGCCTTGGCGGAGCCTCTCTCCG
TAACCGGAACCCTCCGCTGCCGGAAACCTTTCGTCATCCGATGCGCCGGCGAGTCATCTTCAACGGCAGC
AGATTCTGATTTCGATGCGAAAGTGTTCCGTAAGAACTTGGTCCGAAGCAAGAACTACAATCGGAAAGGT
TTTGGCCATAAGGAAGAGACCCTTCAACTCATGGACAGCGAGTACACCAGTGATATTATAAAGACTTTGA
AGGATAATGGAAATGAGTACAGGTGGGGGAACGTGACGGTAAAATTGGCCGAAGCATATGGGTTTTGCTG
GGGTGTGGAGCGAGCTGTCCAAATTGCTTACGAAGCAAGGAAACAGTTCCCCGAAGAAAAGATTTGGATT
ACAAACGAAATTATTCATAATCCGACAGTCAACAAGAGACTAGAGGAAATGAAAGTGGAAAATATTCCAA
TTGATGAAGGGAGGAAACAATTTGAGATTGTAAACAAGGGTGATGTTGTGATATTGCCTGCTTTTGGTGC
TGGAGTGGATGAGATGTTGGCTTTGAGTGATAGGAATGTTCAAATTGTTGATACCACATGCCCATGGGTT
TCCAAGGTTTGGAATACAGTCGAGAAACATAAGAAAGGTGAATACACTTCCATTATTCATGGTAAATATG
CTCATGAGGAGACTATAGCTACTGCATCTTTTGCTGGAACTTACATTATTGTAAAGAACATGAAAGAGGC
AATGTATGTCTGTGATTATATTCTTGGCGGTCAACTTGATGGATCCAGCTCAACAAGAGAGGAGTTTATG
GAGAAATTTAAGAATGCAGTTTCTAAGGGATTTGATCCTGACAAACATCTTGTGAAGGCTGGTATTGCAA
ATCAGACTACAATGCTCAAGGGGGAAACCGAAGAGATTGGGAAACTGGTTGAGAGGACTATGATGCAAAA
GTACGGAGTTGAAAACATTAATGAACACTTCCAAAGCTTTAACACAATTTGCGATGCAACCCAAGAGCGT
CAAGATGCAATGTACAAGATGGTGGAGGAACGTATTGACCTTATGTTAGTTGTTGGAGGATGGAACTCTA
GTAACACTTCTCATCTACAAGAGATTGCAGAGGAACGAGGTATTCCCTCGTATTGGATTGACAGTGAACA
GAGAATAGGTCCTGGAAACAAGATAGCCTACAAGCTAAATCATGGAGAGTTGGTTGAGAAAGAGAACTGG
TTACCAGAGGGTCCCATCACGGTCGGTGTAACATCAGGTGCTTCTACTCCAGATAAGGTTGTGGAAGATG
TTCTCATCAAGGTGTTTGACCTTAAGAGCGAAGAAGCTTTGCAAGTTGCTTAG(配列番号25)
MSVISILPLASKSCLYKSLMSSTHELKALCRPIATLGMCRRGKSVMASKSTSLTTAVSDDGVQRRIGDHH
SNLWDDNFIQSLSSPYGASSYGERAERLIGEVKEIFNSLSRTDGELVSHVDDLLQHLSMVDNVERLGIDR
HFQTEIKVSLDYVYSYWSEKGIGSGRDIVCTDLNTTALGFRILRLHGYTVFPDVFEHFKDQMGRIACSDN
HTERQISSILNLFRASLIAFPGEKVMEEAEIFSATYLKEALQTIPVSSLSQEIQYVLQYRWHSNLPRLEA
RTYIDILQENTKNQMLDVNTKKVLELAKLEFNIFHSLQQNELKSVSRWWKESGFPDLNFIRHRHVEFYTL
VSGIDMEPKHCTFRLSFVKMCHLITVLDDMYDTFGTIDELRLFTAAVKRWDPSTTECLPEYMKGVYTVLY
ETVNEMAQEAQKSQGRDTLSYVRQALEAYIGAYHKEAEWISSGYLPTFDEYFENGKVSSGHRIATLQPTF
MLDIPFPHHVLQEIDFPSKFNDFACSILRLRGDTRCYQADRARGEEASCISCYMKDNPGSTQEDALNHIN
NMIEETIKKLNWELLKPDNNVPISSKKHAFDINRGLHHFYNYRDGYTVASNETKNLVIKTVLEPVPM(配列番号26)
1 mmsfdiakyp tlalvdstqe lrllpkeslp klcdelrryl ldsvsrssgh fasglgtvel
61 tvalhyvynt pfdqliwdvg hqayphkilt grrdkigtir qkgglhpfpw rgeseydvls
121 vghsstsisa gigiavaaek egknrrtvcv igdgaitagm afeamnhagd irpdmlvvln
181 dnemsisenv galnnhlaql lsgklysslr eggkkvfsgv ppikellkrt eehikgmvvp
241 gtlfeelgfn yigpvdghdv lglittlknm rdlkgpqflh imtkkgrgye paekdpitfh
301 avpkfdpssg clpkssgglp syskifgdwl cetaakdnkl maitpamreg sgmvefsrkf
361 pdryfdvaia eqhavtfaag laiggykpiv aiystflqra ydqvlhdvai qklpvlfaid
421 ragivgadgq thqgafdlsy lrcipemvim tpsdenecrq mlytgyhynd gpsavryprg
481 navgveltpl eklpigkgiv krrgeklail nfgtlmpeaa kvaeslnatl vdmrfvkpld
541 ealilemaas healvtveen aimggagsgv nevlmahrkp vpvlniglpd ffipqgtqee
601 mraelgldaa gmeakikawl a(配列番号27)
1 matthldvca vvpaagfgrr mqtecpkqyl signqtileh svhallahpr vkrvviaisp
61 gdsrfaqlpl anhpqitvvd ggderadsvl aglkaagdaq wvlvhdaarp clhqddlarl
121 lalsetsrtg gilaapvrdt mkraepgkna iahtvdrngl whaltpqffp rellhdcltr
181 alnegatitd easaleycgf hpqlvegrad nikitrpedl alaefyltrt ihqent(配列番号28)
1 mrighgfdvh afggegpiii ggvripyekg llahsdgdva lhaltdallg aaalgdigkl
61 fpdtdpafkg adsrellrea wrriqakgyt lgnidvtiia qapkmlphip qmrvfiaedl
121 gchmddvnvk attteklgft grgegiacea vallikatk(配列番号29)
1 mqtehvilln aqgvptgtle kyaahtadtr lhlafsswlf nakgqllvtr ralskkawpg
61 vwtnsvcghp qlgesnedav irrcryelgv eitppesiyp dfryratdps givenevcpv
121 faarttsalq inddevmdyq wcdladilhg idatpwafsp wmvmqatnre arkrlsaftq
181 lk(配列番号30)
MAYSAMATMGYNGMAASCHTLHPTSPLKPFHGASTSLEAFNGEHMGLLRGYSKRKLSSYKNPASRSSNATVAQLLNPPQKGKKAVEFDFNKYMDSKAMTVNEALNKAIPLRYPQKIYESMRYSLLAGGKRVRPVLCIAACELVGGTEELAIPTACAIEMIHTMSLMHDDLPCIDNDDLRRGKPTNHKIFGEDTAVTAGNALHSYAFEHIAVSTSKTVGADRILRMVSELGRATGSEGVMGGQMVDIASEGDPSIDLQTLEWIHIHKTAMLLECSVVCGAIIGGASEIVIERARRYARCVGLLFQVVDDILDVTKSSDELGKTAGKDLISDKATYPKLMGLEKAKEFSDELLNRAKGELSCFDPVKAAPLLGLADYVAFRQN(配列番号31)
1 mdfpqqleac vkqanqalsr fiaplpfqnt pvvetmqyga llggkrlrpf lvyatghmfg
61 istntldapa aavecihays lihddlpamd dddlrrglpt chvkfgeana ilagdalqtl
121 afsilsdadm pevsdrdris miselasasg iagmcggqal dldaegkhvp ldalerihrh
181 ktgaliraav rlgalsagdk grralpvldk yaesiglafq vqddildvvg dtatlgkrqg
241 adqqlgksty pallgleqar kkardlidda rqslkqlaeq sldtsaleal adyiiqrnk(配列番号32)
1 mkqltilgst gsigcstldv vrhnpehfrv valvagknvt rmveqclefs pryavmddea
61 sakllktmlq qqgsrtevls gqqaacdmaa ledvdqvmaa ivgaagllpt laairagkti
121 llankeslvt cgrlfmdavk qskaqllpvd sehnaifqsl pqpiqhnlgy adleqngvvs
181 illtgsggpf retplrdlat mtpdqacrhp nwsmgrkisv dsatmmnkgl eyiearwlfn
241 asasqmevli hpqsvihsmv ryqdgsvlaq lgepdmrtpi ahtmawpnrv nsgvkpldfc
301 klsaltfaap dydrypclkl ameafeqgqa attalnaane itvaaflaqq irftdiaaln
361 lsvlekmdmr epqcvddvls vdanarevar kevmrlas(配列番号33)
1 mrtqwpspak lnlflyitgq radgyhtlqt lfqfldygdt isielrddgd irlltpvegv
61 ehednlivra arlliktaad sgrlptgsga nisidkrlpm ggglgggssn aatvlvalny
121 lwqcglsmde laemgltlga dvpvfvrgha afaegvgeil tpvdppekwy lvahpgvsip
181 tpvifkdpel prntpkrsie tllkcefsnd ceviarkrfr evdavlswll eyapsrltgt
241 gacvfaefdt esearqvleq apewlngfva kgvnlsplhr aml(配列番号34)
1 mhnqapiqrr kstriyvgnv pigdgapiav qsmtntrttd veatvnqika lervgadivr
61 vsvptmdaae afklikqqvn vplvadihfd yrialkvaey gvdclrinpg nigneerirm
121 vvdcardkni pirigvnags lekdlqekyg eptpqalles amrhvdhldr lnfdqfkvsv
181 kasdvflave syrllakqid qplhlgitea ggarsgavks aiglglllse gigdtlrvsl
241 aadpveeikv gfdilkslri rsrginfiac ptcsrqefdv igtvnaleqr lediitpmdv
301 siigcvvngp gealvstlgv tggnkksgly edgvrkdrld nndmidqlea rirakasqld
361 earridvqqv ek(配列番号35)
1 mqillanprg fcagvdrais ivenalaiyg apiyvrhevv hnryvvdslr ergaifieqi
61 sevpdgaili fsahgvsqav rneaksrdlt vfdatcplvt kvhmevaras rrgeesilig
121 haghpevegt mgqysnpegg mylvespddv wkltvkneek lsfmtqttls vddtsdvida
181 lrkrfpkivg prkddicyat tnrqeavral aeqaevvlvv gsknssnsnr laelaqrmgk
241 rafliddakd iqeewvkevk cvgvtagasa pdilvqnvva rlqqlgggea iplegreeni
301 vfevpkelrv direvd(配列番号36)
1 mvsgskagvs phreievmrq siddhlagll petdsqdivs lamregvmap gkrirpllml
61 laardlryqg smptlldlac avelthtasl mlddmpcmdn aelrrgqptt hkkfgesvai
121 lasvgllska fgliaatgdl pgerraqavn elstavgvqg lvlgqfrdln daaldrtpda
181 ilstnhlktg ilfsamlqiv aiasasspst retlhafald fgqafqlldd lrddhpetgk
241 drnkdagkst lvnrlgadaa rqklrehids adkhltfacp qggairqfmh lwfghhladw
301 spvmkia(配列番号37)
1 mkktvvigag fgglalairl qaagiptvll eqrdkpggra yvwhdqgftf dagptvitdp
61 talealftla grrmedyvrl lpvkpfyrlc wesgktldya ndsaeleaqi tqfnprdveg
121 yrrflaysqa vfqegylrlg svpflsfrdm lragpqllkl qawqsvyqsv srfiedehlr
181 qafsfhsllv ggnpfttssi ytlihalere wgvwfpeggt galvngmvkl ftdlggeiel
241 narveelvva dnrvsqvrla dgrifdtdav asnadvvnty kkllghhpvg qkraaalerk
301 smsnslfvly fglnqphsql ahhticfgpr yrelideift gsaladdfsl ylhspcvtdp
361 slappgcasf yvlapvphlg napldwaqeg pklrdrifdy leerympglr sqlvtqrift
421 padfhdtlda hlgsafsiep lltqsawfrp hnrdsdianl ylvgagthpg agipgvvasa
481 kataslmied lq(配列番号38)
MSQPPLLDHATQTMANGSKSFATAAKLFDPATRRSVLMLYTWCRHCDDVIDDQTHGFASEAAAEEEATQRLARLRTL
TLAAFEGAEMQDPAFAAFQEVALTHGITPRMALDHLDGFAMDVAQTRYVTFEDTLRYCYHVAGVVGLMMARVMGVRD
ERVLDRACDLGLAFQLTNIARDIIDDAAIDRCYLPAEWLQDAGLTPENYAARENRAALARVAERLIDAAEPYYISSQ
AGLHDLPPRCAWAIATARSVYREIGIKVKAAGGSAWDRRQHTSKGEKIAMLMAAPGQVIRAKTTRVTPRPAGLWQRP
V(配列番号39)
MATELLCLHRPISLTHKLFRNPLPKVIQATPLTLKLRCSVSTENVSFTETETEARRSANYEPNSWDYDYLLSSDTDE
SIEVYKDKAKKLEAEVRREINNEKAEFLTLLELIDNVQRLGLGYRFESDIRGALDRFVSSGGFDAVTKTSLHGTALS
FRLLRQHGFEVSQEAFSGFKDQNGNFLENLKEDIKAILSLYEASFLALEGENILDEAKVFAISHLKELSEEKIGKEL
AEQVNHALELPLHRRTQRLEAVWSIEAYRKKEDANQVLLELAILDYNMIQSVYQRDLRETSRWWRRVGLATKLHFAR
DRLIESFYWAVGVAFEPQYSDCRNSVAKMFSFVTIIDDIYDVYGTLDELELFTDAVERWDVNAINDLPDYMKLCFLA
LYNTINEIAYDNLKDKGENILPYLTKAWADLCNAFLQEAKWLYNKSTPTFDDYFGNAWKSSSGPLQLVFAYFAVVQN
IKKEEIENLQKYHDTISRPSHIFRLCNDLASASAEIARGETANSVSCYMRTKGISEELATESVMNLIDETWKKMNKE
KLGGSLFAKPFVETAINLARQSHCTYHNGDAHTSPDELTRKRVLSVITEPILPFER(配列番号40)
Claims (50)
- 二官能性ispDF酵素をコードする核酸に機能的に連結した異種プロモーターを含む発現カセット。
- 前記二官能性ispDF酵素が、以下のispDF酵素、H.pylori HP1020、H.pylori J99 jhp0404、H.pylori HPAG1 HPAG1_0427、H.hepaticus HH1582、H.acinonychis st.Sheeba Hac_1124、W.succinogenes DSM 1740 WS1940、S.denitrificans DSM 1251 Suden_1487、C.jejuni subsp.jejuni NCTC 11168Cj1607、C.jejuni RM1221 CJE1779、C.jejuni subsp.jejuni 81−176 CJJ81176_1594、及び、C.fetus subsp.fetus 82−40 CFF8240_0409と、少なくとも1つのアミノ酸が異なる、請求項1に記載の発現カセット。
- 前記二官能性ispDF酵素をコードする前記核酸に機能的に連結した前記プロモーターが、構成的プロモーターである、請求項1に記載の発現カセット。
- 前記二官能性ispDF酵素をコードする前記核酸に機能的に連結した前記プロモーターが、誘導性プロモーターである、請求項1に記載の発現カセット。
- 前記二官能性ispDF酵素が、配列番号1、配列番号2、または、配列番号3の300個の連続したアミノ酸に対して、少なくとも50%、または、55%が同一であるアミノ酸配列を含む、請求項1に記載の発現カセット。
- 前記二官能性ispDF酵素をコードする核酸が、コドン最適化したものである、請求項1に記載の発現カセット。
- 前記発現カセットが、dxs、idi、及び、ispEからなる群から選択した1つ以上、2つ以上、または、すべての酵素をコードする核酸をさらに含む、請求項1に記載の発現カセット。
- 前記発現カセットが、dxs、及び、idiをコードする核酸をさらに含む、請求項1に記載の発現カセット。
- 前記発現カセットが、dxs、idi、及び、ispEをコードする核酸をさらに含む、請求項1に記載の発現カセット。
- 前記二官能性ispDFが、CJ−ispDFに対して、31%以下が類似している、請求項1に記載の発現カセット。
- 請求項1〜10のいずれか1項に記載の発現セットを含むプラスミド。
- 前記プラスミドが、イソプレンシンターゼ(ispS)をコードする核酸を含む発現カセットをさらに含む、請求項11に記載のプラスミド。
- 前記プラスミドが、GPPシンターゼをコードする核酸を含む発現カセットをさらに含む、請求項11に記載のプラスミド。
- 前記GPPシンターゼが、真核生物由来のGPPシンターゼである、請求項11に記載のプラスミド。
- 前記GPPシンターゼが、植物由来のGPPシンターゼである、請求項14に記載のプラスミド。
- 前記GPPシンターゼをコードする前記核酸が、コドン最適化したものである、請求項14に記載のプラスミド。
- GPPシンターゼをコードする前記核酸を含む前記発現カセットが、リコピン合成経路(例えば、crtE、crt1、及び/または、crtB)、または、モノテルペンシンターゼの1つ以上の成分をコードする核酸をさらに含む、請求項13に記載のプラスミド。
- GPPシンターゼをコードする前記核酸を含む前記発現カセットが、カレンシンターゼ、ミルセンシンターゼ、または、リモネンシンターゼをコードする核酸をさらに含む、請求項13に記載のプラスミド。
- GPPシンターゼをコードする前記核酸を含む前記発現カセットが、カンナビノイドシンターゼをコードする核酸をさらに含む、請求項13に記載のプラスミド。
- 前記カンナビノイドシンターゼを、Cannabis CBGAシンターゼ、THCAシンターゼ、CBDAシンターゼ、及び、CBCAシンターゼからなる群から選択する、請求項19に記載のプラスミド。
- 請求項1〜10の発現カセットのいずれか1つ、及び/または、請求項11〜20のプラスミドのいずれか1つを含む宿主細胞。
- 宿主細胞であって:
a.二官能性ispDF酵素をコードする核酸に機能的に連結した異種プロモーターを含む発現カセット;及び
b.テルペノイドシンターゼをコードする核酸に機能的に連結した異種プロモーターを含む発現カセット、を含む前記宿主細胞。 - 前記テルペノイドシンターゼが、イソプレンシンターゼである、請求項22に記載の宿主細胞。
- 前記テルペノイドシンターゼが、リコピン合成経路の成分である、請求項22に記載の宿主細胞。
- 前記テルペノイドシンターゼが、カンナビノイドシンターゼである、請求項22に記載の宿主細胞。
- 前記カンナビノイドシンターゼを、CBGAシンターゼ、THCAシンターゼ、CBDAシンターゼ、及び、CBCAシンターゼ、好ましくは、Cannabis属のシンターゼからなる群から選択する、請求項25に記載の宿主細胞。
- 前記カンナビノイドシンターゼが、THCAシンターゼ、CBDAシンターゼ、及び、CBCAシンターゼからなる群から選択する切断したカンナビノイドシンターゼであり、前記切断が、シグナルペプチドの全部または一部の欠失である、請求項26に記載の宿主細胞。
- GPPシンターゼをコードする核酸に機能的に連結した異種プロモーターを含む発現カセットを含む、請求項22に記載の宿主細胞。
- a)またはb)の前記発現カセットが、GPPシンターゼをコードする核酸をさらに含む、請求項22に記載の宿主細胞。
- 前記宿主細胞が、1つ以上の発現カセットの少なくとも1つを含まないコントロール細胞と比較して、MEP経路を通るフラックスの増加を示す、請求項22に記載の宿主細胞。
- 前記宿主細胞が、ispC、ispE、ispG、または、ispHをコードする異種核酸;それらの組み合わせ;または、それらのすべてを含まない、請求項22に記載の宿主細胞。
- 前記細胞が、原核生物である、請求項22〜31のいずれか1項に記載の宿主細胞。
- a)及び/またはb)の前記発現カセットが、前記宿主細胞のゲノムに組み込まれている、請求項22〜32のいずれか1項に記載の宿主細胞。
- 前記宿主細胞が、プロモーターに機能的に連結したカンナビノイドシンターゼをコードする核酸を含み、かつ、前記カンナビノイドシンターゼをコードする核酸に機能的に連結したプロモーターが、構成的プロモーターである、請求項22〜33のいずれか1項に記載の宿主細胞。
- 前記宿主細胞が、プロモーターに機能的に連結したカンナビノイドシンターゼをコードする核酸を含み、かつ、前記カンナビノイドシンターゼをコードする核酸に機能的に連結したプロモーターが、誘導性プロモーターである、請求項22〜33のいずれか1項に記載の宿主細胞。
- a)の前記発現カセット、及び、b)の前記発現カセットが、単一のプラスミドに存在しており、または、単一の遺伝子座で前記宿主細胞のゲノムに挿入される、請求項22〜35のいずれか1項に記載の宿主細胞。
- a)の前記発現カセット、及び、b)の前記発現カセットが、異なるプラスミドにあり、または、異なる遺伝子座で前記宿主細胞のゲノムに挿入される、請求項22〜35のいずれか1項に記載の宿主細胞。
- 前記宿主細胞が、オリベトール酸(OA)をさらに含む、請求項22〜37のいずれか1項に記載の宿主細胞。
- 前記オリベトール酸が、前記宿主細胞に対して外因性である、請求項38に記載の宿主細胞。
- 前記宿主細胞が、1つ以上のグリコシル化経路遺伝子をコードする核酸に機能的に連結した異種プロモーターを含む発現カセットを含む、請求項22〜39のいずれか1項に記載の宿主細胞。
- 前記宿主細胞が、ackA−pta、poxB、ldhA、dld、adhE、pps、及び、atoDAからなる群から選択する1つ、2つ、3つ、4つ、5つ、6つ、または、すべての遺伝子に欠失を含む、請求項22〜40のいずれか1項に記載の宿主細胞。
- 標的代謝産物を得る方法であって、請求項22〜41のいずれか1項に記載の宿主細胞を、1つ以上の宿主細胞発現カセットで発現を誘導するのに適した条件下で、適切な培地で培養し、次いで、培養した細胞、または、使用済培地を回収し、それにより、前記標的代謝産物を得ることを含む、前記方法。
- 前記代謝産物が、カンナビノイドである、請求項42に記載の方法。
- 前記カンナビノイドが、THCA、CBDA、CBCA、CBN、THC、CBD、または、CBC、または、それらの1つ以上の混合物である、請求項43に記載の方法。
- 前記代謝産物が、テルペノイド、または、イソプレンである、請求項42に記載の方法。
- 前記方法が、前記培養細胞を回収、及び、溶解し、それにより、細胞溶解物を生産することを含む、請求項42〜45のいずれか1項に記載の方法。
- 前記方法が、前記細胞溶解物から前記標的代謝産物を精製し、それにより、精製した標的代謝産物を生産することを含む、請求項46に記載の方法。
- 前記方法が、前記使用済培地から前記標的代謝産物を精製し、それにより、精製した標的代謝産物を生産することを含む、請求項42〜45のいずれか1項に記載の方法。
- 前記精製した標的代謝産物が、カンナビノイドであり、かつ、前記方法が、医薬組成物にカンナビノイドを処方することを含む、請求項47または48に記載の方法。
- 前記精製した標的代謝産物が、カンナビノイドであり、かつ、前記方法が、前記精製カンナビノイドの塩、プロドラッグ、または、溶媒和物を形成することを含む、請求項47または48に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762554494P | 2017-09-05 | 2017-09-05 | |
US62/554,494 | 2017-09-05 | ||
PCT/CA2018/051074 WO2019046941A1 (en) | 2017-09-05 | 2018-09-05 | METABOLIC ENGINEERING OF E. COLI FOR BIOSYNTHESIS OF CANNABINOID PRODUCTS |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020532307A true JP2020532307A (ja) | 2020-11-12 |
JP2020532307A5 JP2020532307A5 (ja) | 2021-10-14 |
Family
ID=65633427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020513274A Pending JP2020532307A (ja) | 2017-09-05 | 2018-09-05 | カンナビノイド産物の生合成のためのE.Coliの代謝工学 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20200291434A1 (ja) |
EP (1) | EP3679146A4 (ja) |
JP (1) | JP2020532307A (ja) |
KR (1) | KR20200070237A (ja) |
CN (1) | CN111433364A (ja) |
AU (1) | AU2018329232A1 (ja) |
CA (1) | CA3074748A1 (ja) |
IL (1) | IL272919A (ja) |
SG (1) | SG11202001924XA (ja) |
WO (1) | WO2019046941A1 (ja) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020069214A2 (en) * | 2018-09-26 | 2020-04-02 | Demetrix, Inc. | Optimized expression systems for producing cannabinoid synthase polypeptides, cannabinoids, and cannabinoid derivatives |
WO2020176547A1 (en) | 2019-02-25 | 2020-09-03 | Ginkgo Bioworks, Inc. | Biosynthesis of cannabinoids and cannabinoid precursors |
EP3935178A4 (en) * | 2019-03-06 | 2023-03-29 | Inmed Pharmaceuticals Inc. | COMPOSITIONS AND METHODS FOR BIOSYNTHESIS OF TERPENOIDS OR CANNABINOIDS IN A HETEROLOGOUS SYSTEM |
CA3136629A1 (en) * | 2019-04-12 | 2020-10-15 | Renew Biopharma, Inc. | Compositions and methods for using genetically modified enzymes |
EP3766982A1 (en) | 2019-07-18 | 2021-01-20 | Delft Advanced Biofuels B.V. | Integrated system for biocatalytically producing and recovering an organic substance |
US11041002B1 (en) | 2019-09-03 | 2021-06-22 | Cb Therapeutics, Inc. | Malonate transporters |
JP2022551901A (ja) * | 2019-10-11 | 2022-12-14 | ナショナル ユニヴァーシティ オブ シンガポール | 新規カンナビノイドシンターゼを使用したカンナビゲロール酸からのカンナビノイドの生合成 |
CA3172499A1 (en) | 2020-03-27 | 2021-09-30 | Mathias Schuetz | Compositions and methods for recombinant biosynthesis of cannabinoids |
CA3173509A1 (en) * | 2020-04-14 | 2021-10-21 | Deqiang Zhang | Cannabinoid synthase variants and methods for their use |
EP4142711A1 (en) | 2020-04-29 | 2023-03-08 | Willow Biosciences Inc. | Compositions and methods for enhancing recombinant biosynthesis of cannabinoids |
US20210355434A1 (en) * | 2020-05-14 | 2021-11-18 | EVN Holdings LLC | Methods of Producing Cannabinoids |
WO2022125960A1 (en) | 2020-12-11 | 2022-06-16 | Willow Biosciences, Inc. | Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors |
CN113186183B (zh) * | 2021-04-30 | 2023-05-16 | 中国科学院昆明植物研究所 | 双功能二倍半萜/二萜合酶LcTPS2、编码基因及其产物和应用 |
CA3227215A1 (en) | 2021-07-30 | 2023-02-02 | Trish Choudhary | Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids |
CA3227236A1 (en) | 2021-08-19 | 2023-02-23 | Trish Choudhary | Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids |
WO2023069921A1 (en) | 2021-10-19 | 2023-04-27 | Epimeron Usa, Inc. | Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids |
CN116949063B (zh) * | 2023-09-12 | 2023-12-12 | 中国热带农业科学院三亚研究院 | 一种低温响应转录因子及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006515174A (ja) * | 2002-12-19 | 2006-05-25 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 染色体組込みにより細菌において増加するカロテノイド産生 |
WO2011127589A1 (en) * | 2010-04-15 | 2011-10-20 | National Research Council Of Canada | Genes and proteins for aromatic polyketide synthesis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2990071C (en) * | 2014-07-14 | 2023-01-24 | Librede Inc. | Production of cannabigerolic acid |
CN106434507B (zh) * | 2016-09-29 | 2019-12-31 | 中国科学院天津工业生物技术研究所 | 生产β-胡萝卜素的重组微生物及构建方法与应用 |
-
2018
- 2018-09-05 KR KR1020207009683A patent/KR20200070237A/ko not_active Application Discontinuation
- 2018-09-05 WO PCT/CA2018/051074 patent/WO2019046941A1/en unknown
- 2018-09-05 EP EP18853185.9A patent/EP3679146A4/en active Pending
- 2018-09-05 CA CA3074748A patent/CA3074748A1/en active Pending
- 2018-09-05 JP JP2020513274A patent/JP2020532307A/ja active Pending
- 2018-09-05 SG SG11202001924XA patent/SG11202001924XA/en unknown
- 2018-09-05 US US16/644,484 patent/US20200291434A1/en active Pending
- 2018-09-05 CN CN201880071332.5A patent/CN111433364A/zh active Pending
- 2018-09-05 AU AU2018329232A patent/AU2018329232A1/en active Pending
-
2020
- 2020-02-26 IL IL272919A patent/IL272919A/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006515174A (ja) * | 2002-12-19 | 2006-05-25 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 染色体組込みにより細菌において増加するカロテノイド産生 |
WO2011127589A1 (en) * | 2010-04-15 | 2011-10-20 | National Research Council Of Canada | Genes and proteins for aromatic polyketide synthesis |
Non-Patent Citations (4)
Title |
---|
BIOCHEMISTRY, vol. 45, JPN7022003563, 2006, pages 3548 - 3553, ISSN: 0005038684 * |
BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1764, JPN7022003560, 2006, pages 85 - 96, ISSN: 0005038683 * |
BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1800, JPN7022003561, 2010, pages 919 - 928, ISSN: 0005038682 * |
EUR. J. BIOCHEM., vol. 271, JPN7022003562, 2004, pages 3028 - 3035, ISSN: 0005038681 * |
Also Published As
Publication number | Publication date |
---|---|
KR20200070237A (ko) | 2020-06-17 |
CN111433364A (zh) | 2020-07-17 |
CA3074748A1 (en) | 2019-03-14 |
US20200291434A1 (en) | 2020-09-17 |
WO2019046941A1 (en) | 2019-03-14 |
AU2018329232A1 (en) | 2020-03-19 |
EP3679146A1 (en) | 2020-07-15 |
SG11202001924XA (en) | 2020-04-29 |
IL272919A (en) | 2020-04-30 |
EP3679146A4 (en) | 2021-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2020532307A (ja) | カンナビノイド産物の生合成のためのE.Coliの代謝工学 | |
US11981938B2 (en) | Microorganisms and methods for the fermentation of cannabinoids | |
Kumar et al. | Indoleamine 2, 3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors | |
Mast et al. | Characterization of the ‘pristinamycin supercluster’of Streptomyces pristinaespiralis | |
Thibodeaux et al. | Enzymatic chemistry of cyclopropane, epoxide, and aziridine biosynthesis | |
US20220170056A1 (en) | Compositions and methods for biosynthesis of terpenoids or cannabinoids in a heterologous system | |
US11274320B2 (en) | Biosynthesis of cannabinoids and cannabinoid precursors | |
Meganathan et al. | Biosynthesis of menaquinone (vitamin K2) and ubiquinone (coenzyme Q) | |
US20220170057A1 (en) | Microorganisms and methods for the fermentation of cannabinoids | |
Rishavy et al. | Vitamin K oxygenation, glutamate carboxylation, and processivity: defining the three critical facets of catalysis by the vitamin K–dependent carboxylase | |
WO2020069214A2 (en) | Optimized expression systems for producing cannabinoid synthase polypeptides, cannabinoids, and cannabinoid derivatives | |
CA3151799A1 (en) | Biosynthesis of cannabinoids and cannabinoid precursors | |
CN114729337A (zh) | 优化的大麻素合酶多肽 | |
US20230137139A1 (en) | Biosynthesis of cannabinoids and cannabinoid precursors | |
EP4031657A1 (en) | Optimized tetrahydrocannabinolic acid (thca) synthase polypeptides | |
Ranjit et al. | Characterization of a bacterial kinase that phosphorylates dihydrosphingosine to form dhS1P | |
CA3175683A1 (en) | Compositions and methods for enhancing recombinant biosynthesis of cannabinoids | |
Hannappel et al. | Bacterial model systems for cytochrome c oxidase biogenesis | |
He | Characterizing the stabilizing effect of the putative kinase Coq8 and the function of the Coq9 polypeptide in yeast coenzyme Q biosynthesis | |
García‐Fernández et al. | Cholesterol metabolism in Mycobacterium smegmatis | |
Smart | A Partial Characterization of Three Photosynthetic Regulatory Genes in Rhodobacter Capsulatus | |
Hsieh | Characterization of the coenzyme Q biosynthetic genes ABC1/COQ8 and COQ9 in yeast Saccharomyces cerevisiae | |
Barkley | Type I and type II IPP isomerases from Methanothermobacter thermautotrophicus, Synechocystis 6803, and Halobacterium sp. NRC-1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210903 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20210903 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20220727 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220802 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20221101 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230202 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20230418 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230817 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20231017 |
|
A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20231215 |